nicotine has been researched along with piperidines in 192 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 50 (26.04) | 18.7374 |
| 1990's | 19 (9.90) | 18.2507 |
| 2000's | 70 (36.46) | 29.6817 |
| 2010's | 51 (26.56) | 24.3611 |
| 2020's | 2 (1.04) | 2.80 |
| Authors | Studies |
|---|---|
| Haines, H; Randle, H | 1 |
| Hecht, SS; Hoffmann, D; Ornaf, RM | 1 |
| Fujiwara, M; Muramatsu, I; Nakashima, M; Shikimi, T | 1 |
| Abood, LG; Lowy, K; MacNeil, M; Tometsko, A | 1 |
| Hecht, SS; Mirvish, SS; Sams, J | 1 |
| Kawashima, K; Shimizu, M; Sohji, Y | 1 |
| Hecht, SS; Hilfrich, J; Hoffmann, D | 1 |
| Hecht, SS; Hoffmann, D; Maronpot, R; Raineri, R; Wynder, EL | 1 |
| Gorrod, JW; Lam, SP; Whittlesea, CM | 1 |
| Markus, JK; Mylecharane, EJ; Phillips, CA; Shaw, J | 2 |
| Iwamoto, ET | 1 |
| Robbins, TW | 1 |
| Kumar, S; Martin, WR; Sloan, JW | 1 |
| Dusting, GJ; Li, DM | 1 |
| Barbieri, RL; Cherry, ML; Ryan, KJ; York, CM | 1 |
| Culver, PJ; Rattan, S | 1 |
| Barbieri, RL; Gochberg, J; Ryan, KJ | 1 |
| Hayashi, E; Kagawa, Y; Takayanagi, N; Ushijima, H; Yamada, S | 1 |
| Hook, R; Kaplan, E; Martin, WR; Sloan, JW; Wash, C | 1 |
| Janssen, PA; Reyntjens, AJ; Schuurkes, JA; Van Daele, PG; Van Nueten, JM | 1 |
| Hernandez, J; Hook, R; Martin, WR; Sloan, JW | 1 |
| Bostwick, M; Hook, R; Howell, A; Martin, WR; Sloan, JW; Smith, WT | 1 |
| Habib, AA; Hassan, MM; Muhtedi, FJ | 1 |
| Neurath, G | 1 |
| Haefely, W | 1 |
| Faeder, IR; O'Brien, RD; Salpeter, MM | 1 |
| Baik, SI; Kramarenko, VF | 1 |
| Baĭk, SI | 2 |
| Borg, KO; Holgersson, H; Lagerström, PO | 1 |
| Baik, SI; Kramarenko, VP | 1 |
| Burger, A; Reed, FD | 1 |
| Alps, BJ; Fidler, K; Hill, M; Johnson, ES; Wilson, AB | 1 |
| Fontaine, J; Janssen, PA; Van Nueten, JM | 1 |
| Baudis, J; Staib, AH | 1 |
| Jenner, P; Testa, B | 1 |
| Gorrod, JW; Jenner, P | 1 |
| Gandiha, A; Marshall, IG | 1 |
| Corrado, L; Felsenfeld, H; Kubilus, J | 1 |
| Upshall, DG | 1 |
| Kasé, Y; Miyata, T; Yuizono, T | 1 |
| Kimura, K; Nagasawa, H; Nomura, A; Ohata, K; Shimomura, S | 1 |
| Coutts, RT; Hubbard, JW; Midha, KK; Prasad, K | 1 |
| Heilbronn, E; Järlebark, L; Lawoko, G | 1 |
| Ernsberger, P; Evinger, MJ; Joh, TH; Regunathan, S; Reis, DJ | 1 |
| Bobbin, RP; Erostegui, C; Norris, CH | 1 |
| Bohn, AA; Forsyth, CS; Frank, AA; Watrous, BJ | 1 |
| Araujo, DM; Hefti, F; Lapchak, PA | 1 |
| Cascieri, M; Hargreaves, RJ; Hill, RG; Marmont, N; Rycroft, W; Tattersall, FD | 1 |
| Andrews, P; Matsuki, N; Saito, H; Torii, Y | 1 |
| Ea-Kim, L; Javellaud, J; Oudart, N | 1 |
| Ohnishi, H | 1 |
| Dement, WC; Mignot, E; Nishino, S; Reid, MS; Siegel, JM; Tafti, M | 1 |
| Carstens, E; Handwerker, HO; Kuenzler, N | 1 |
| Hagan, J; Hatcher, JP; Lewis, VA; Reavill, C; Sanger, GJ | 1 |
| Eaton, BM; Sooranna, SR | 1 |
| Chavez-Noriega, LE; Cosford, ND; Holsenback, H; Lloyd, GK; McDonald, IA; Menzaghi, F; Rao, TS; Reid, R; Sacaan, AI; Suto, CM; Urrutia, A; Vernier, JM; Washburn, MS; Whitten, JP | 1 |
| Ngan, MP; Rudd, JA; Wai, MK | 1 |
| Carstens, E; Dessirier, JM; Nguyen, N; O'Mahony, M; Sieffermann, JM | 1 |
| Acs, Z; Makara, GB; Némethy, Z | 1 |
| Gillberg, PG; Nordberg, A; Sihver, W; Svensson, AL | 1 |
| Beyreuther, K; Emilien, G; Maloteaux, JM; Masters, CL | 1 |
| Branchek, TA; Calligaro, DO; Czachura, JF; Dreshfield-Ahmad, LJ; Evans, DC; Hemrick-Luecke, SK; Kallman, MJ; Kendrick, WT; Leander, JD; Nelson, DL; Overshiner, CD; Rasmussen, K; Wainscott, DB; Wolff, MC; Wong, DT; Xu, YC; Zgombick, JM | 1 |
| Andrews, PL; Hagiwara, H; Kakaimoto, S; Matsuki, N; Okada, F; Toyoda, M; Woods, AJ | 1 |
| Hallberg, A; Lindström, S; Ripa, L | 1 |
| Naves, LA; Van der Kloot, W | 1 |
| Efange, SM; Francesconi, L; Howell, RC; Kung, MP; Papke, RL; Rampersad, MV; Todaro, LJ; Tu, Z; von Hohenberg, K | 1 |
| Cohen, C; Perrault, G; Soubrié, P; Steinberg, R; Voltz, C | 1 |
| Bontempi, B; Lloyd, GK; Menzaghi, F; Risbrough, VB; Whelan, KT | 1 |
| Friedman, L; Kraemer, HC; Lee, H; Mumenthaler, MS; O'Hara, R; Taylor, JL; Yesavage, JA | 1 |
| HAZARD, R; SAVINI, E | 1 |
| CORNE, SJ; EDGE, ND | 1 |
| MANNAIONI, PF | 1 |
| MONTAGNA, W; SAKURAI, M | 1 |
| VANOV, S | 1 |
| Hayslett, RL; Tizabi, Y | 2 |
| Bernardi, G; Di Angelantonio, S; Mercuri, NB | 2 |
| Hashimoto, T; Kurosawa, M; Shimada, T; Terano, A; Yoneda, M | 1 |
| Kosowski, AR; Liljequist, S | 1 |
| Cohen, C; Griebel, G; Perrault, G; Soubrié, P | 1 |
| Baviera, M; Calcagno, E; Carli, M; Ceglia, I; Invernizzi, RW; Renoldi, G | 1 |
| JOHNSON, CC; JOHNSON, G; POE, CF | 1 |
| Goldberg, SR; Le Foll, B | 1 |
| Häkkinen, ST; Laakso, I; Maaheimo, H; Oksman-Caldentey, KM; Rischer, H; Seppänen-Laakso, T | 1 |
| Caricati-Neto, A; D'angelo, LC; Garcia, AG; Hyppolito Jurkiewicz, N; Jurkiewicz, A; Reuter, H | 1 |
| De Vries, TJ; de Vries, W; Janssen, MC; Schoffelmeer, AN | 1 |
| Forget, B; Hamon, M; Thiébot, MH | 1 |
| Camarelles Guillem, F | 1 |
| Arias, E; Gallego-Sandín, S; García, AG; López, MG; Villarroya, M | 1 |
| Damaj, MI; Martin, BR; Papke, RL; Wiley, JL | 1 |
| Borel, ML; Guevel-Jointret, AL; Mansourati, J; Munier, S | 1 |
| Aso, E; Balerio, GN; Maldonado, R | 1 |
| Corelli, RL; Hudmon, KS | 1 |
| Anggadiredja, K; Hiranita, T; Nawata, Y; Sakimura, K; Yamamoto, T | 1 |
| Kuehn, BM | 1 |
| Barthélémy, S; Forget, B; Hamon, M; Saurini, F; Thiébot, MH | 1 |
| Bumgarner, DM; Miller, DK; Putnam, WC; Rodvelt, KR | 1 |
| González-Cuevas, G; López-Moreno, JA; Navarro, M | 1 |
| Bura, SA; Castañé, A; Ledent, C; Maldonado, R; Valverde, O | 1 |
| Frishman, WH | 1 |
| Blackwelder, WP; Caldwell, DP; Christopher, NC; Kao, M; Kholdebarin, E; Levin, ED | 1 |
| Cohen, C; Griebel, G; Kodas, E; Louis, C | 1 |
| Filip, M; McCreary, AC; Przegaliński, E; Zaniewska, M | 1 |
| Blokland, A; Riedel, WJ; Sambeth, A; Smits, LT | 1 |
| Bermudez-Silva, FJ; Gallego, A; Lamota, L; Llorente, R; Marco, EM; Rodríguez de Fonseca, F; Viveros, MP | 1 |
| Calabro, S; Kelsey, JE | 1 |
| Cunnane, TC; Cuprian-Beltechi, AM; Solanki, P | 1 |
| Shoaib, M | 1 |
| Cahill, K; Lancaster, T; Stead, L | 1 |
| Wonnacott, S | 1 |
| Damaj, MI; Lichtman, AH; Martin, BR; Merritt, LL; Walters, C | 1 |
| Aubin, HJ; Forget, B; Goldberg, SR; Le Foll, B | 1 |
| Buchhalter, AR; Fant, RV; Henningfield, JE | 1 |
| Biala, G; Kruk, M | 1 |
| De Vries, TJ; de Vries, W; Diergaarde, L; Raasø, H; Schoffelmeer, AN | 1 |
| Alcayaga, J; Del Rio, R; Fujiwara, K; Iturriaga, R; Koenig, CS; Moya, EA | 1 |
| Aydin, C; Bhatti, AS; Hall, P; Isgor, C; Ma, Z; Oztan, O; Tao, R | 1 |
| Cho, GW; Kim, HY; Kim, SH; Kim, Y; Koh, SH; Noh, MY | 1 |
| Goldberg, SR; Luchicchi, A; Melis, M; Muntoni, AL; Pillolla, G; Pistis, M; Yasar, S | 1 |
| Chang, Y; Dale, LC; Gonzales, D; Lawrence, D; Rigotti, NA | 1 |
| Aveyard, P; Hajek, P; Inglis, J; Parsons, AC; Shraim, M | 1 |
| Izenwasser, S; Reed, SC; Wade, D; Werling, LL | 1 |
| Kwiatkowska, M; Limebeer, CL; Litt, DL; Parker, LA; Piomelli, D; Rock, EM | 1 |
| Filip, M; McCreary, AC; Zaniewska, M | 1 |
| Biala, G; Budzynska, B; Staniak, N | 1 |
| Bushell, K; Huffman, JW; Martin, BR; Vann, RE; Warner, JA; Wiley, JL | 1 |
| Coen, KM; Forget, B; Le Foll, B | 1 |
| Li, N; Sun, DW; Zhang, QG; Zhou, R; Zhu, FG | 1 |
| Bevins, RA; Lyford, GD; Murray, JE; Wells, NR | 1 |
| Deissenrieder, F; Groneberg, D; Kusma, B; Mache, S; Quarcoo, D; Welte, T | 1 |
| Das, JR; Tizabi, Y | 1 |
| Cagniard, B; Murphy, NP; Shoaib, M; Wing, VC | 1 |
| Biala, G; Budzynska, B; Kruk, M | 1 |
| Kamei, C; Masuoka, T | 1 |
| Baarendse, PJ; Trezza, V; Vanderschuren, LJ | 1 |
| Burza, A; Grabowska, I; Kaliszan, M; Kaliszan, R; Radecka, H; Radecki, J | 1 |
| Buccafusco, JJ; Hall, BJ; Pearson, LS | 1 |
| Drott, JT; Hutson, PH; Sharik, SS; Sur, C; Theberge, CR; Uslaner, JM; Williams, DL; Zeng, Z | 1 |
| Crooks, PA; Deaciuc, AG; Dwoskin, LP; Pivavarchyk, M; Subramanian, KL; Zhang, Z | 1 |
| Akaike, A; Fujii, T; Izumi, Y; Kume, T; Niidome, T; Sugimoto, H; Takada-Takatori, Y | 1 |
| Filip, M; McCreary, AC; Wydra, K; Zaniewska, M | 1 |
| Carroll, FI; Damaj, MI; Jackson, KJ; Negus, SS | 1 |
| Shoaib, M; Wing, VC | 2 |
| Bhat, A; Crain, D | 1 |
| Atcha, Z; Aw, CC; Browne, ER; Goh, CW; Lim, JS; Neo, AH; Pemberton, DJ; Rourke, C | 1 |
| Markou, A; Semenova, S | 1 |
| Bevins, RA; Murray, JE; Polewan, RJ; Walker, AW | 1 |
| Crich, D; Delpech, B; Marazano, C; Nguyen, TM; Peixoto, S | 1 |
| Cauley, M; Cousins, V; Hampton, D; Levin, ED; Petro, A; Pruitt, M; Rose, J; Slade, S; Wells, C | 1 |
| Calapai, G; Caputi, AP; Mannucci, C; Navarra, M; Pieratti, A; Russo, GA | 1 |
| Coen, KM; Gamaleddin, I; Goldberg, SR; Le Foll, B; Makryannis, A; Vemuri, K; Wertheim, C; Zhu, AZ | 1 |
| Nath, C; Patro, IK; Saxena, G | 1 |
| Fang, Q; He, YY; Li, FQ; Li, YQ; Liu, JF; Lu, L; Wang, JS; Xue, YX | 1 |
| Hayase, T | 2 |
| Alijanpour, S; Rezayof, A; Zarrindast, MR | 1 |
| Lecca, S; Luchicchi, A; Melis, M; Muntoni, AL; Pistis, M | 1 |
| Aveyard, P; Farley, AC; Hajek, P; Lycett, D | 1 |
| Fletcher, PJ; Higgins, GA; Lê, AD; Noble, K; Rizos, Z; Silenieks, LB; Soko, AD | 1 |
| Cador, M; Caille, S; Simonnet, A | 1 |
| Aydin, C; Isgor, C; Oztan, O | 1 |
| Hayes, MR; Kimmey, BA; Rupprecht, LE; Schmidt, HD | 1 |
| Bifone, A; Cassina, C; Cervo, L; Corsi, M; Di Clemente, A; Gozzi, A; Moro, F; Orrù, A; Pich, EM | 1 |
| Albuquerque, EX; Alkondon, M; Pereira, EF | 1 |
| Berrendero, F; Flores, Á; Maldonado, R; Martín-García, E; Plaza-Zabala, A; Saravia, R | 1 |
| Benowitz, NL; Goniewicz, ML; Havel, CM; Jacob, P; Schick, SF | 1 |
| Hashemizadeh, S; Rezayof, A; Sardari, M | 1 |
| Connor, DA; Gould, TJ; Poole, RL | 1 |
| Di Ciano, P; Diaz, J; Khaled, MA; Le Foll, B; Pushparaj, A | 1 |
| Ishibashi, M; Miledi, R; Sumikawa, K; Yamazaki, Y | 1 |
| Fletcher, PJ; Guy, EG | 1 |
| Abdullah, RA; Chen, J; Chen, X; Cravatt, BF; Damaj, MI; Harenza, JL; Lichtman, AH; Miles, MF; Muldoon, PP; Sim-Selley, LJ | 1 |
| Biala, G; Kruk-Slomka, M; Michalak, A | 1 |
| Grayson, B; Harte, MK; Marsh, S; McLean, SL; Neill, JC; Zarroug, SH | 1 |
| Le Foll, B; Trigo, JM | 1 |
| Ashare, RL; Bowers, ME; Hayes, MR; Kimmey, BA; Rupprecht, LE; Schmidt, HD | 1 |
| Goldberg, SR; Justinova, Z; Makriyannis, A; Redhi, GH; Scherma, M; Schindler, CW; Vadivel, SK | 1 |
| Forget, B; Gamaleddin, I; Goldberg, SR; Guranda, M; Le Foll, B | 1 |
| Bergman, J; Goldberg, SR; Justinova, Z; Le Foll, B; Makriyannis, A; Redhi, GH; Schindler, CW; Vemuri, K | 1 |
| Berrendero, F; Busquets-Garcia, A; de la Torre, R; Di Marzo, V; Flores, Á; Maldonado, R; Marsicano, G; Ozaita, A; Pastor, A; Plaza-Zabala, A; Saravia, R | 1 |
| Cravatt, BF; de Fonseca, FR; Martin-Fardon, R; Parsons, LH; Pavon, FJ; Polis, I; Serrano, A; Sidhpura, N; Stouffer, D | 1 |
| Alaei, H; Azizi, F; Fartootzadeh, R; Reisi, P | 3 |
| Abbasnezhad, A; Abd El-Ghafar, OA; Abhilash, L; Abouzid, KAM; Achberger, AM; Ackerman, S; Akhatayeva, Z; Akin, D; Al-Kaysi, RO; Alakhdar, AA; Alame, M; Aleksic Sabo, V; Alinezhadbalalami, N; Allen, JD; Alonso, JM; Alqatani, S; Alsayed, B; Álvarez Larraondo, M; Alvarez, M; Amini, SB; An, Z; Anasir, MI; Anderson, GH; Andremont, A; Andrés, S; Angel, S; Anigboro, AA; Anini, Y; Antonides, CFJ; Arafa, K; Arafa, RK; Aryal, UK; Asbaghi, O; Assefa, MK; Atyah, M; Avwioroko, OJ; Ayora-Talavera, G; Azpilikueta, A; Azyazov, VN; Ba, YF; Bachmann, KF; Badoual, J; Bae, SJ; Baek, SH; Bahrami, B; Bai, J; Baid-Agrawal, S; Bailey, MR; Baillie, JK; Balani, N; Balcar, VJ; Banica, T; Banks, L; Barb, J; Bardeen, CJ; Barrett, HE; Bartnikowski, N; Bashir, R; Battaglia, M; Bautista-Hernández, V; Becker, B; Beekman, FJ; Benidir, M; Benjelloun, M; Bentley, RF; Bergé, J; Berger, D; Bernsen, MR; Berraondo, P; Bhattacharya, R; Bhayani, SB; Bi, W; Bi, X; Bi, YL; Bi, Z; Bian, K; Biesecker, LG; Billadeau, DD; Blaszczyk, R; Blum, JL; Boachie, R; Boelte, K; Bogers, AJJC; Boileau, I; Bonduelle, C; Bonny, O; Bonsu, JM; Boos, LA; Borges-Argáez, R; Bouchard, PA; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, E; Boyle, AJ; Branigan, D; Briones, S; Broniowska, KA; Brossas, JY; Brown, WA; Brzezinska, J; Buitron, G; Burnier, M; Bursulaya, B; Burton, PR; Bush, AA; Busuttil, RW; Cabello-Aguilar, S; Cáceres-Farfán, M; Cacheux, V; Caffrey, PJ; Cai, B; Cai, Q; Cai, S; Cai, Y; Calders, P; Cammarota, G; Campbell, DA; Cancelli, C; Cao, Q; Cao, WH; Cao, X; Capet, M; Capoluongo, E; Carey, ME; Carnero, M; Carrasco, LI; Carreno, J; Carrillo-Reyes, J; Casini, I; Cassar, M; Catalan, G; Cattamanchi, A; Cazares-Granillo, M; Celie, B; Cen, YK; Cena, H; Cerbo, RM; Ceron, E; Cetina-Montejo, L; Chaâbane-Banaoues, R; Chabanet, C; Chace-Donahue, F; Chalfun-Júnior, A; Chan-Balan, R; Chang, CS; Chen, CS; Chen, D; Chen, J; Chen, L; Chen, PN; Chen, Q; Chen, S; Chen, W; Chen, WP; Chen, X; Chen, Z; Cheng, H; Cheng, J; Cheng, Q; Cheng, T; Chi, T; Chianelli, D; Chieppa, M; Child, CJ; Cho, JH; Cho, JY; Chogtu, B; Choi, GH; Choi, J; Choi, M; Choi, NG; Cholu, CO; Chow, ES; Chowdhury, AH; Chu, PC; Chu, Q; Chu, S; Chua, H; Chung, T; Chunyan, L; Church, JS; Civardi, E; Cobiella, J; Colinge, J; Collado, CJ; Collins, TJ; Cong, LM; Conkrite, KL; Cope, SJ; Corbett, JA; Cornet, M; Cornillot, E; Corvaisier, S; Costes-Martineau, V; Courtioux, B; Coussens, M; Covino, M; Criado, A; Cui, J; Cui, Y; Cunitz, BW; Curry, AE; Cussó, L; D'Urzo, AD; D'Urzo, KA; Dabbous, S; Dahlgren, RA; Dai, H; Dai, T; Dai, W; Dalinghaus, M; Dang, S; Davalos, RV; Davidson, H; de Andrea, CE; De Angelis, M; de Blois, E; de Carvalho, PA; De Clercq, E; De Giuseppe, R; de Jong, M; De Langhe, S; De Oliveira, L; de Souza Pinto Lemgruber, R; de Souza, LB; de Swart, J; De Wandele, I; de Woestijne, PCV; Delaney, S; Delorme, M; Delvenne, P; Deng, L; Deng, Z; Denkinger, CM; der Meulen, MHV; Deraeve, C; Desco, M; DeSilva, S; Destere, A; Dhali, A; Di Ciano, P; Dias-Santagata, D; Diskin, SJ; Djè, MK; Doddipatla, S; Doerr, AJ; Dokla, EME; Domiciano, D; Domingo, N; Dong, C; Dong, J; Dong, Q; Dong, S; Dong, X; Dong, Z; Douair, I; Douglas, TA; Doyle, SM; Drain, PK; Du, K; Du, L; Du, Q; Du, S; Duan, C; Duan, H; Duan, J; Duan, S; Duan, W; Dueluzeau, R; Dukic, L; Dunmire, BL; Duvauchelle, T; Dymek, B; Dzwonek, K; Earnest, A; Eckardt, KU; El Ghadraoui, L; El Massoudi, S; Elloumi, F; Elnour, IE; Embarak, S; Ende, M; England, K; Enikeev, D; Enyedy, I; Epple, R; Erickson, GE; Eriksson, J; Erndt-Marino, J; Errachidi, F; Etxeberria, I; Evan, AP; Fairlamb, AH; Falahi, E; Fan, CC; Fan, H; Fan, M; Fan, MZ; Fan, S; Fan, Y; Fang, CS; Fang, J; Fang, X; Fang, Z; Farmany, A; Farooqi, A; Farouk, HO; Fazelipour, S; Feng, D; Feng, J; Feng, JX; Feng, YL; Ferraz, SL; Ferreira, CR; Figenshau, RS; Finn, AV; Fiseha, T; Fleischer, AS; Fogleman, AD; Fontaine, O; Ford, CR; Fouladvand, F; Four, M; Fousteri, G; Francis, JR; Fraser, JF; Frazier, RP; Fu, H; Fu, P; Fu, YJ; Fujishima, A; Fuster, V; Gabilan, JC; Gagliani, N; Gai, QY; Galán-Arriola, C; Gale, P; Galimova, GR; Galkin, A; Gallo, A; Gallo, AA; Gang, DD; Ganschow, S; Gao, C; Gao, F; Gao, GP; Gao, H; Gao, K; Gao, M; Gao, MY; Gao, P; Gao, R; Gao, S; Gao, WJ; Gao, Y; Garbacz, P; García Ruiz, L; Garcia, EM; Garofoli, F; Gasbarrini, A; Gattinoni, L; Gaudig, M; Gbureck, U; Ge, X; Genko, N; Gentile, GL; George, MW; Gerety, GF; Gestwicki, JE; Geusens, PP; Ghassemi, M; Giardina, JD; Giebultowicz, JM; Gifford, CA; Gijsen, FJH; Gilfillan, R; Gilson, E; Gingl, K; Giuliano, C; Glybochko, P; Goessler, W; Gofflot, S; Golab, J; Goldstein, A; Golebiowski, A; Gómez, L; Gómez-Carballo, J; Gonçalves, PEO; Gonzales, R; Gonzalez-Cotto, M; González-Fernández, D; Gonzalez-Lopez de Turiso, F; Goodman, JM; Govinda Raju, S; Grimm, J; Gross, AJ; Gruenheid, S; Gu, C; Gu, FF; Gu, S; Gu, Z; Guest, RL; Gui, C; Gui, J; Guillem, A; Guo, G; Guo, L; Guo, Q; Guo, S; Guo, SW; Guo, W; Guo, Y; Guo, YG; Guo, Z; Guretzky, JA; Haenggi, M; Hahn, MS; Hakkola, J; Halim, AA; Hampel, D; Han, B; Han, BH; Han, D; Han, G; Han, J; Han, LZ; Han, R; Han, S; Han, X; Han, Z; Handley, MA; Hanke, I; Hannongbua, S; Hao, P; Happ, JT; Hara, M; Haraux, F; Hare, JL; Harper, JD; Hartley, AM; Harvey, E; Hashimoto, K; Hassan, HM; Hautajärvi, H; Hayton, TW; He, C; He, H; He, HJ; He, WP; He, Y; He, Z; Hedrick, V; Heffernan, JK; Hegrová, J; Heidarimoghadam, R; Helms, K; Hengphasatporn, K; Henry, D; Herrmann, TRW; Hesson, T; Himmelbauer, MK; Hindle, A; Hoffmann, R; Hogg, N; Hong, KB; Hong, SK; Honjol, Y; Hood, C; Hsi, RS; Hsu, JL; Hu, B; Hu, BC; Hu, D; Hu, H; Hu, J; Hu, K; Hu, M; Hu, MK; Hu, T; Hu, W; Hu, Y; Hu, Z; Hua, S; Huang, H; Huang, J; Huang, L; Huang, M; Huang, P; Huang, X; Huang, Y; Huang, Z; Hukkanen, J; Hung, MC; Huo, X; Hyötyläinen, T; Ianiro, G; Ibanez, B; Imran, M; Ireland, S; Irwin, MS; Ishiguro, H; Jackowski, K; Jackson, C; Jacob, SI; Jahromy, MH; Jakob, SM; Jang, J; Javvaji, PK; Jefferson, KK; Jena, P; Ji, H; Jiang, F; Jiang, GH; Jiang, H; Jiang, J; Jiang, X; Jiang, Z; Jiao, J; Jiménez, A; Jin, X; Jincai, W; Jintao, X; Jo, K; Jofra, T; Johari, Y; Johnson, ACM; Jones, JH; Josephine Fauci, A; Juhl, AK; Jun, S; Kaiser, RI; Kajioka, J; Kajiyama, H; Kalliyil, A; Kalthur, SG; Kamalanathan, M; Kamaldinov, T; Kanaani, L; Kang, D; Kang, J; Kang, S; Känsäkoski, P; Kaplan, DL; Karwan, M; Kasibhatla, S; Kaur, A; Kawazoe, Y; Ke, C; Keyser, J; Khalique, A; Khan, IT; Kharshoum, RM; Kher, R; Kherani, J; Ki, KK; Kikkawa, F; Kikkawa, R; Kim, BT; Kim, EH; Kim, GA; Kim, GD; Kim, HB; Kim, HG; Kim, JS; Kim, MJ; Kim, SI; Kim, SJ; Kim, Y; King, K; Kinyamu-Akunda, J; Kirkkala, T; Kjaer-Sorensen, K; Kleppinger, EL; Kloner, RA; Klopfenstein, TJ; Knappe, D; Knezevic, P; Kobos, LM; Kohli, M; Kolano, L; Kolodgie, FD; Kolte, AP; Koneru, B; Kong, D; Kong, F; Kong, X; Konggidinata, MI; Köpke, M; Koski, KG; Kotsis, F; Köttgen, A; Kouakou-Kouamé, CA; Kraemer, US; Krane, V; Krehbiel, CR; Krenning, BJ; Kretzschmar, D; Ku, KB; Kubota, Y; Kulich, P; Kumar, NG; Kupiec-Weglinski, JW; Lalani, SS; Lan, X; Landfeldt, E; Langenberg, E; Lapauw, B; Larkin, J; Lassoued, MA; Laukhtina, E; Laura Martinez, J; Laveillé, A; Lavela, P; Law, AD; Lazraq, A; Le Foll, B; Lee, BK; Lee, C; Lee, CS; Lee, EJ; Lee, EY; Lee, G; Lee, HY; Lee, JH; Lee, JJ; Lee, JO; Lee, JS; Lee, R; Lei, H; Lei, P; Lellouche, F; Lennerz, JK; Leong, W; Leslie, I; Lessem, E; Levin, M; Levinger, I; Li, C; Li, CW; Li, CX; Li, CY; Li, D; Li, H; Li, HM; Li, J; Li, L; Li, LM; Li, N; Li, S; Li, W; Li, X; Li, XX; Li, Y; Li, Z; Li, ZL; Li, ZX; Lian, Q; Liang, C; Liang, GH; Liang, H; Liang, J; Liang, X; Liao, CX; Liao, R; Ličbinský, R; Lim, YS; Lima, HK; Lin, JG; Lin, L; Lin, S; Lin, WP; Lin, Z; Liso, M; Liu, BX; Liu, C; Liu, H; Liu, J; Liu, M; Liu, Q; Liu, S; Liu, SF; Liu, SL; Liu, T; Liu, W; Liu, X; Liu, XB; Liu, Y; Liu, YY; Liu, Z; Liu, ZQ; Lobo, M; Loitzenbauer, M; López, F; Lopez, G; López, GJ; Lou, Z; Lu, IC; Lu, J; Lu, M; Lu, W; Lu, X; Lu, Y; Luhovyy, BL; Luna-Abanto, J; Luo, J; Luo, K; Luo, L; Luo, M; Luo, W; Luo, X; Luo, XM; Lv, Y; Lv, YQ; Lyu, HD; Lyu, J; Ma, C; Ma, G; Ma, L; Ma, Q; Ma, X; Ma, Y; Macha, SJ; MacLean, E; Mahalapbutr, P; Maina, T; Malfait, F; Malfertheiner, MV; Malzert-Fréon, A; Mansouri, E; Mao, C; Marcellin, E; Marchiori, PER; Marcotte, DJ; Maréchal, A; Maric, N; Maris, JM; Maron, L; Marti, CN; Martínez-Milla, J; Mateo, J; Mather, K; Mathison, CJN; Matthay, MA; Maxwell, CL; Mazier, D; Mazumder, D; Mazurkiewicz, M; Mazzucchelli, TG; McAuley, DF; Mccoy, K; McVicar, DW; Mebel, AM; Mech, A; Meester, EJ; Meiselbach, H; Melero, I; Ménard, G; Meng, X; Mengya, Y; Merle, G; Meunier, B; Mfarrej, B; Mi, K; Migueliz, I; Mikuška, P; Miladi, K; Miletich, R; Millar, JE; Mills, MR; Milne, R; Minute, L; Misiak, M; Mo, F; Modi, A; Mok, F; Molina, C; Mollen, CJ; Molteni, V; Montalto, M; Montet, D; Monti, MC; Moor, MB; Moravec, P; Morsiani, C; Murillo, E; Murugan, P; Muslem, R; Myers, RK; N'guessan, FK; Nabil, H; Nadal, J; Nadeem, M; Nafady, MM; Nafie, MS; Nair, HP; Nakano, R; Nance, J; Naren, N; Neil, CJ; Nelson, J; Nery, FC; Netsch, C; Nguyen, TH; Ni, L; Ni, YX; Nie, W; Nielsen, LK; Nigam, K; Nikolayev, AA; Nishiyama, M; Niu, LL; Niu, PP; Nock, BA; Noer, PR; Noll, G; Noll, S; Norenberg, JP; Nowicka, J; Nutho, B; O'Connor, M; Obonyo, NG; Ochiai, T; Ochoa, MC; Oh, BL; Oh, S; Olczak, J; Olivares, X; Ommurugan, B; Oosthuizen, MC; Operario, D; Orešič, M; Oshima, K; Otano, I; Ou, Y; Owen, TW; Oxvig, C; Pacey, V; Pai, M; Paik, H; Paiva, R; Palmieri, EM; Palpant, N; Pan, L; Pan, Q; Panahi, S; Pang, B; Pang, ZC; Pannecouque, C; Paris, L; Park, D; Park, DJ; Park, E; Park, EC; Park, IH; Park, JH; Park, JI; Park, S; Passmore, MR; Pattaranggoon, NC; Paun, M; Pedersen, S; Pedron, J; Peng, M; Peng, X; Penzhorn, BL; Pérez-Camargo, D; Perez-Maldonado, R; Pérez-Vicente, C; Pham, TD; Pickering, L; Pickersgill, NA; Pinault, E; Pinotsis, N; Plan, M; Pocino, K; Poh, CL; Pons, EDC; Popoff, MR; Porri, D; Pourmand, A; Pratviel, G; Prudente, DO; Qi, H; Qi, N; Qian, LY; Qiao, L; Qiao, Q; Qin, QP; Qiu, N; Qiu, SW; Qu, F; Quan, M; Quigg, A; Raee, E; Raibaud, P; Ramanitrahasimbola, D; Rapoport, L; Rasby, RJ; Rasoanirina, BNV; Raspini, B; Ratner, JR; Razafindrakoto, Z; Redd, MA; Ren, H; Ren, N; Rey, J; Reynolds, CP; Rich, PR; Richards, CJ; Rigol, M; Rimoldi, S; Robert, P; Rodrigues, AE; Roe, JH; Rohde, S; Rokita, JL; Roland, J; Rombaut, L; Ronkainen, J; Rothenberg, SM; Roy, SC; Ruan, Z; Rucker, PV; Rueda, D; Ruhwald, M; Rungrotmongkol, T; Rupert, AS; Rusjan, P; Ryabov, AD; Rysä, J; Saad, NES; Sabioni, P; Sadow, PM; Sahai, N; Salem, HF; Salinas, B; Salonurmi, T; Samé Guerra, D; Sánchez, J; Sanchez-González, J; Sanmamed, MF; Sansores-Peraza, P; Santoro, JC; Santschi, PH; Saritas, T; Sarkisova, Y; Savolainen, MJ; Scherberich, JE; Schlom, DG; Schmelz, EM; Schmid, MC; Schneider, MP; Schumacher, S; Schwartz, JC; Schwartzer, JJ; Schwehr, K; Schweitzer, DH; Scott, ME; Sedky, NK; See Hoe, L; Sejian, V; Selvaraju, S; Sen, SK; Seo, G; Šerý, O; Settles, JA; Sfar, S; Shaffer, J; Shan, GL; Shang, Q; Shannahan, JH; Shao, B; Shao, H; Shao, J; Shao, ZH; Shasha, Y; Shaw, K; Sheeba, V; Shekar, K; Shen, G; Shen, H; Shen, XD; Shen, Y; Sherrell, PC; Shete, PB; Shi, AX; Shi, J; Shi, JH; Shi, S; Shi, X; Shigeta, Y; Shimbo, A; Shin, E; Sikka, N; Silhavy, TJ; Simanon, N; Simard, S; Simon, J; Simon, M; Simpson, SD; Simundic, AM; Since, M; Singh, B; Singhroy, DN; Sinisterra, OT; Smith, EH; Sobreira, TJP; Solanes, N; Somasundar, Y; Sommerer, C; Sonei, A; Song, B; Song, E; Song, J; Song, M; Song, Y; Soo Lee, M; Sorensen, MD; Sournia-Saquet, A; Spaepen, E; Spirk, D; Srivastava, S; Stancill, JS; Stanczak, PS; Starenki, D; Starr, F; Step, DL; Steubl, D; Stigliani, JL; Stráská, J; Sträter, N; Su, ZZ; Sudano, I; Suen, JY; Suh, HJ; Sui, ZY; Suico, JG; Suleiman, K; Sumon, K; Sun, HB; Sun, J; Sun, L; Sun, LL; Sun, M; Sun, Q; Sun, W; Sun, X; Sun, XF; Sun, Y; Sun, YB; Sun, YH; Sun, YN; Sun, Z; Sunada, K; Suzuki, S; Sylvan, JB; Takala, J; Talla, D; Tamir, Z; Tan, SJ; Tanda, S; Tang, H; Tang, J; Tang, LF; Tang, SJ; Tang, Y; Tao, FB; Tappel, R; Taratkin, M; Teijeira, Á; Tellew, JE; Thomas, AM; Thomas, SG; Thomson, SR; Tian, J; Tie, Y; Tirado, JL; Tolonen, A; Tosato, G; Tronnet, A; Tsai, S; Turtoi, A; Turtoi, E; Tvrdoňová, M; Tyagi, A; Tzou, DT; Uddin Ahmad, Z; Urias, E; Usawachintachit, M; Ustriyana, P; Utsumi, F; Vacca, M; Vaculovič, T; Vaidya, SS; Valentin, A; Valgepea, K; van den Berg, P; van den Bergh, JP; van der Heiden, K; van Gaalen, K; Van Gemert, W; van Haard, PMM; van Hest, JCM; Vecchiarelli, E; Večeřa, Z; Venkatesh, R; Verhaeghe, P; Verhagen, HJ; Vetter, JM; Vieira, D; Vilchez-Tschischke, JP; Villena-Gutierrez, R; Villoslada Terrones, V; Vital-Jacome, M; Voelkl, J; Vogel, K; Vogrin, S; Volke, D; von Bahr, V; Vysloužil, J; Wade, TL; Wagner-Gillespie, M; Walsh, SW; Wan, LJ; Wan, SP; Wang, AL; Wang, B; Wang, BY; Wang, C; Wang, D; Wang, F; Wang, H; Wang, HR; Wang, HY; Wang, J; Wang, JY; Wang, K; Wang, L; Wang, LF; Wang, P; Wang, Q; Wang, R; Wang, SF; Wang, SP; Wang, SR; Wang, T; Wang, W; Wang, WP; Wang, X; Wang, XJ; Wang, Y; Wang, YL; Wang, YN; Wáng, YXJ; Wang, Z; Wang, ZF; Wang, ZY; Waning, B; Warner, JM; Washington, SL; Watson, AK; Wei, B; Wei, C; Wei, F; Wei, X; Wei, Y; Wemhoff, AP; Wen, Z; Weng, TT; Wesdemiotis, C; Wheeler, DA; Wildner, M; Wilson, BK; Wirth, LJ; Wissler, M; Wu, F; Wu, G; Wu, J; Wu, KH; Wu, MC; Wu, P; Wu, PK; Wu, S; Wu, W; Wu, X; Wu, XP; Wu, Y; Wyatt, E; Wyllie, S; Xia, Y; Xiao, BH; Xiao, SZ; Xiao, W; Xiao, X; Xiao, Z; Xie, D; Xie, K; Xie, X; Xie, Y; Xie, YF; Xin, S; Xin, Z; Xing, Q; Xing, WQ; Xiong, D; Xiong, X; Xu, C; Xu, D; Xu, F; Xu, G; Xu, H; Xu, J; Xu, JY; Xu, L; Xu, N; Xu, W; Xu, X; Xu, Y; Xu, YM; Xue, H; Xue, J; Xue, Z; Yan, R; Yan, SQ; Yan, W; Yan, X; Yan, Z; Yang, C; Yang, D; Yang, F; Yang, FC; Yang, G; Yang, J; Yang, M; Yang, P; Yang, Q; Yang, R; Yang, S; Yang, SJ; Yang, TWW; Yang, X; Yang, Y; Yang, Z; Yao, C; Yao, L; Yao, LP; Yao, M; Yao, T; Yao, W; Yao, Y; Yaseen, T; Yazdani, V; Ye, J; Ye, S; Yerys, BE; Yi, HWL; Yi, JL; Yin, F; Yin, J; Yin, Y; Yin, Z; Yong, ZP; Yongli, S; Yoo, JS; Yoshikawa, N; You, Q; Yu, B; Yu, CQ; Yu, H; Yu, HG; Yu, J; Yu, L; Yu, Q; Yu, X; Yu, Y; Yu, YK; Yu, Z; Yuan, Q; Yuan, R; Yuan, W; Yuan, X; Yuan, Y; Zager, RA; Zagozdzon, A; Zaller, N; Zang, YP; Zappi, ME; Zelikoff, JT; Zeman, T; Zhai, X; Zhan, P; Zhang, B; Zhang, C; Zhang, G; Zhang, H; Zhang, HB; Zhang, J; Zhang, JS; Zhang, L; Zhang, M; Zhang, Q; Zhang, RX; Zhang, S; Zhang, T; Zhang, W; Zhang, WH; Zhang, X; Zhang, XX; Zhang, Y; Zhang, YQ; Zhang, YW; Zhang, Z; Zhang, ZH; Zhao, D; Zhao, FL; Zhao, K; Zhao, L; Zhao, M; Zhao, R; Zhao, S; Zhao, W; Zhao, WG; Zhao, X; Zhao, Y; Zheng, G; Zheng, J; Zheng, S; Zheng, W; Zheng, Y; Zheng, YG; Zhong, Z; Zhou, C; Zhou, D; Zhou, H; Zhou, HY; Zhou, L; Zhou, Q; Zhou, X; Zhou, Y; Zhou, YL; Zhou, Z; Zhu, J; Zhu, L; Zhu, N; Zhu, X; Zhu, XF; Zhu, Y; Zhu, Z | 1 |
| Akinola, LS; Cravatt, BF; Damaj, MI; Lichtman, AH; Mahadevan, A; Muldoon, PP; Schlosburg, JE; Sim-Selley, LJ | 1 |
| Foster Olive, M; Gipson, CD; Leyrer-Jackson, JM; McCallum, J; Piña, JA | 1 |
11 review(s) available for nicotine and piperidines
| Article | Year |
|---|---|
[Nitrogen compounds of tobacco smoke].
Topics: Acridines; Alkaloids; Alkanes; Amines; Amino Acids; Aniline Compounds; Carbazoles; Cyanates; Indoles; Isoquinolines; Ketones; Niacinamide; Nicotiana; Nicotine; Nicotinic Acids; Nitriles; Nitrites; Nitrosamines; Piperidines; Plants, Toxic; Pyrazines; Pyridines; Pyrroles; Pyrrolidines; Quinolines; Quinoxalines; Smoking | 1969 |
Prospects for pharmacological intervention in Alzheimer disease.
Topics: Alzheimer Disease; Amyloid Precursor Protein Secretases; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Aspartic Acid Endopeptidases; Cholinesterase Inhibitors; Clinical Trials as Topic; Donepezil; Endopeptidases; Hippocampus; Humans; Indans; N-Methylaspartate; Nerve Growth Factors; Nicotine; Piperidines; Tacrine | 2000 |
[Medications in smoking cessation].
Topics: Administration, Cutaneous; Adult; Antidepressive Agents, Second-Generation; Bupropion; Cannabinoid Receptor Antagonists; Cannabinoids; Central Nervous System Stimulants; Chewing Gum; Child; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Piperidines; Polymethacrylic Acids; Polyvinyls; Pyrazoles; Rimonabant; Smoking Cessation; Surveys and Questionnaires; Time Factors; Tobacco Use Cessation Devices | 2005 |
Pharmacologic interventions for smoking cessation.
Topics: Administration, Cutaneous; Administration, Inhalation; Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Chewing Gum; Clonidine; Critical Care; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Nicotine; Nicotinic Agonists; Nortriptyline; Nurse's Role; Patient Education as Topic; Patient Selection; Phytotherapy; Piperidines; Pyrazoles; Quinoxalines; Rimonabant; Smoking Cessation; Smoking Prevention; United States; United States Food and Drug Administration; Varenicline | 2006 |
Smoking cessation pharmacotherapy--nicotine and non-nicotine preparations.
Topics: Administration, Cutaneous; Administration, Inhalation; Benzazepines; Bupropion; Chewing Gum; Clonidine; Coronary Artery Disease; Humans; Monoamine Oxidase Inhibitors; Nicotine; Nortriptyline; Piperidines; Pyrazoles; Quinoxalines; Receptors, Nicotinic; Rimonabant; Selective Serotonin Reuptake Inhibitors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Tobacco, Smokeless; Varenicline | 2007 |
An update on therapeutics for tobacco dependence.
Topics: Alkaloids; Anti-Anxiety Agents; Azocines; Benzazepines; Bupropion; Clinical Trials as Topic; Databases, Bibliographic; Humans; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Quinolizines; Quinoxalines; Review Literature as Topic; Rimonabant; Smoking; Smoking Cessation; Varenicline | 2008 |
Blocking cannabinoid CB1 receptors for the treatment of nicotine dependence: insights from pre-clinical and clinical studies.
Topics: Animals; Brain; Cannabinoid Receptor Modulators; Clinical Trials as Topic; Drug Evaluation, Preclinical; Emotions; Humans; Motivation; Nicotine; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Secondary Prevention; Smoking Cessation; Tobacco Use Disorder | 2008 |
Novel pharmacological approaches for treating tobacco dependence and withdrawal: current status.
Topics: Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Clonidine; Cytochrome P-450 CYP2A6; Drug Delivery Systems; GABA Modulators; Humans; Narcotic Antagonists; Nicotine; Piperidines; Pyrazoles; Receptors, Nicotinic; Rimonabant; Substance Withdrawal Syndrome; Tobacco Use Disorder; Vaccination | 2008 |
Interventions for preventing weight gain after smoking cessation.
Topics: Antidepressive Agents; Benzazepines; Exercise; Female; Humans; Male; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Quinoxalines; Rimonabant; Smoking Cessation; Varenicline; Weight Gain | 2009 |
Interventions for preventing weight gain after smoking cessation.
Topics: Antidepressive Agents; Benzazepines; Exercise; Female; Humans; Male; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Quinoxalines; Randomized Controlled Trials as Topic; Smoking Cessation; Weight Gain | 2012 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
4 trial(s) available for nicotine and piperidines
| Article | Year |
|---|---|
Cisapride improves nicotine-evoked antral hypomotility in smokers.
Topics: Adult; Cisapride; Cross-Over Studies; Female; Gastrointestinal Motility; Humans; Male; Manometry; Nicotine; Piperidines; Pyloric Antrum; Smoking | 1997 |
Psychoactive drugs and pilot performance: a comparison of nicotine, donepezil, and alcohol effects.
Topics: Adult; Aircraft; Area Under Curve; Central Nervous System Depressants; Cholinesterase Inhibitors; Donepezil; Double-Blind Method; Ethanol; Female; Humans; Indans; Male; Middle Aged; Motor Skills; Nicotine; Nicotinic Agonists; Piperidines; Psychomotor Performance; Psychotropic Drugs; Space Simulation; Time Factors | 2003 |
A randomized controlled trial of adding the nicotine patch to rimonabant for smoking cessation: efficacy, safety and weight gain.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Counseling; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Odds Ratio; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome; Weight Gain; Young Adult | 2009 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
178 other study(ies) available for nicotine and piperidines
| Article | Year |
|---|---|
Effect of water deprivation on antidiuresis in Dipodomys spectabilis and Rattus norvegicus.
Topics: Animals; Body Weight; Diuresis; Female; Kidney; Nicotine; Piperidines; Rats; Species Specificity; Urine; Water Deprivation | 1976 |
IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans: some N-nitroso compounds.
Topics: Animals; Butylamines; Carcinogens; Diethylnitrosamine; Dimethylnitrosamine; Ethanolamines; Ethylamines; Ethylnitrosourea; Folic Acid; Humans; Methylamines; Methylnitrosourea; Morpholines; Nicotine; Nitrosamines; Nitroso Compounds; Piperidines; Proline; Propylamines; Research Design; Sarcosine; Streptozocin | 1978 |
Chemical studies on tobacco smoke. XXXIII. N' -nitrosonornicotine in tobacco: analysis of possible contributing factors and biologic implications.
Topics: Alkaloids; Anabasine; Carboxylic Acids; Chromatography, Gas; Hydrogen-Ion Concentration; Mass Spectrometry; Methyl Ethers; Nicotiana; Nicotine; Nitrates; Nitrites; Nitrosamines; Piperidines; Plants, Toxic; Pyridines; Pyrrolidines | 1975 |
Effects of loperamide on the guinea pig taenia coli.
Topics: Acetylcholine; Animals; Colon; Drug Interactions; Electric Stimulation; Female; Guinea Pigs; In Vitro Techniques; Loperamide; Male; Morphine; Muscle Contraction; Muscle, Smooth; Naloxone; Nicotine; Piperidines; Serotonin | 1979 |
Evidence for a noncholinergic site for nicotine's action in brain: psychopharmacological, electrophysiological and receptor binding studies.
Topics: Animals; Behavior, Animal; Brain; Electroencephalography; Electrophysiology; Injections, Intraventricular; Male; Nicotine; Piperidines; Rats; Receptors, Drug | 1979 |
Kinetics of nornicotine and anabasine nitrosation in relation to N'-nitrosonornicotine occurrence in tobacco and to tobacco-induced cancer.
Topics: Anabasine; Animals; Humans; In Vitro Techniques; Kinetics; Neoplasms; Nicotiana; Nicotine; Nitrosamines; Piperidines; Plants, Toxic; Smoking; Tobacco, Smokeless | 1977 |
[Pharmacological studies of loperamide, an anti-diarrheal agent. III. Interaction between loperamide and various agonists in the guinea pig intestine (author's transl)].
Topics: Acetylcholine; Animals; Antidiarrheals; Barium; Bradykinin; Calcium; Guinea Pigs; Histamine Antagonists; Ileum; In Vitro Techniques; Intestines; Loperamide; Male; Muscle Contraction; Muscle, Smooth; Nicotine; Physical Stimulation; Piperidines; Prostaglandins E; Serotonin Antagonists | 1978 |
A study of tobacco carcinogenesis. XV. Effects of N'-nitrosonornicotine and N'-nitrosoanabasine in Syrian golden hamsters.
Topics: Anabasine; Animals; Cricetinae; Female; Male; Mesocricetus; Neoplasms, Experimental; Nicotiana; Nicotine; Nitrosamines; Nose Neoplasms; Piperidines; Plants, Toxic; Smoking; Tracheal Neoplasms | 1977 |
A study of tobacco carcinogenesis. XIV. Effects of N'-nitrosonornicotine and N'-nitrosonanabasine in rats.
Topics: Anabasine; Carcinogens; Gastrointestinal Neoplasms; Neoplasms, Experimental; Nicotiana; Nicotine; Nitroso Compounds; Piperazines; Piperidines; Plants, Toxic; Respiratory Tract Neoplasms; Smoking; Tobacco, Smokeless | 1975 |
Trapping of reactive intermediates by incorporation of 14C-sodium cyanide during microsomal oxidation.
Topics: Amines; Animals; Cricetinae; Dogs; Guinea Pigs; Haplorhini; In Vitro Techniques; Male; Mice; Microsomes, Liver; Nicotine; Oxidation-Reduction; Piperidines; Rabbits; Rats; Sodium Cyanide; Species Specificity | 1991 |
Evidence for a central component to the hypotensive action of ketanserin in the dog.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Dogs; Ganglionic Blockers; Hexamethonium Compounds; Ketanserin; Mecamylamine; Nicotine; Norepinephrine; Piperidines; Vasoconstriction | 1985 |
Antinociception after nicotine administration into the mesopontine tegmentum of rats: evidence for muscarinic actions.
Topics: Analgesia; Animals; Male; Microinjections; Nicotine; Phencyclidine; Piperidines; Pirenzepine; Pons; Rats; Rats, Inbred Strains; Receptors, Muscarinic; Scopolamine; Tegmentum Mesencephali | 1989 |
Alzheimer's disease. Arresting memory decline.
Topics: Alzheimer Disease; Animals; Carbolines; Cholinesterase Inhibitors; Humans; Memory Disorders; Nicotine; Piperidines; Rats; Receptors, Cholinergic; Receptors, GABA-A; Receptors, Nicotinic; Thiazoles | 1988 |
Hypotensive actions of ketanserin in dogs: involvement of a centrally mediated inhibition of sympathetic vascular tone.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Dogs; Female; Heart Rate; Hexamethonium; Hexamethonium Compounds; Ketanserin; Male; Mecamylamine; Nicotine; Piperidines; Sympathetic Nervous System; Vascular Resistance; Vasomotor System | 1985 |
Opioid and nicotinic medullary hyperalgesic influences in the decerebrated rat.
Topics: Analgesics, Opioid; Animals; Cyclazocine; Cystine; Decerebrate State; Endorphins; Ethylketocyclazocine; Female; Hyperalgesia; Hyperesthesia; Lobeline; Medulla Oblongata; Nicotine; Piperidines; Rats; Rats, Inbred Strains | 1988 |
Catecholamine release and potentiation of thromboxane A2 production by nicotine in the greyhound.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Blood Pressure; Catecholamines; Dioxanes; Dogs; Epinephrine; Female; Heart Rate; Idazoxan; Imidazoles; In Vitro Techniques; Ketanserin; Male; Nicotine; Phenoxybenzamine; Piperidines; Thromboxane A2; Vasoconstriction | 1986 |
The effects of nicotine, cotinine and anabasine on rat adrenal 11 beta-hydroxylase and 21-hydroxylase.
Topics: Adrenal Glands; Anabasine; Animals; Binding, Competitive; Cotinine; Kinetics; Male; Microsomes; Mitochondria; Nicotine; Piperidines; Pyrrolidinones; Rats; Rats, Inbred Strains; Steroid 11-beta-Hydroxylase; Steroid 21-Hydroxylase; Steroid Hydroxylases | 1987 |
Influence of loperamide on the internal anal sphincter in the opossum.
Topics: Anal Canal; Animals; Drug Interactions; Electric Stimulation; Female; Isoproterenol; Loperamide; Male; Naloxone; Nicotine; Opossums; Piperidines; Pressure; Rectum; Spinal Nerve Roots; Verapamil | 1987 |
Nicotine, cotinine, and anabasine inhibit aromatase in human trophoblast in vitro.
Topics: Anabasine; Androstenedione; Aromatase Inhibitors; Carbachol; Cells, Cultured; Choriocarcinoma; Cotinine; Decamethonium Compounds; Dose-Response Relationship, Drug; Estradiol; Female; Hexamethonium Compounds; Humans; In Vitro Techniques; Kinetics; Microsomes; Nicotine; Piperidines; Placenta; Pregnancy; Pyrrolidinones; Smoking; Succinylcholine; Trophoblasts; Uterine Neoplasms | 1986 |
Effect of piperidine and related alicyclic amines on nicotinic and muscarinic agonist binding sites in the mammalian brain.
Topics: Amines; Animals; Animals, Newborn; Binding, Competitive; Brain; Guinea Pigs; In Vitro Techniques; Mice; Nicotine; Parasympathomimetics; Piperidines; Rabbits; Rats; Rats, Inbred Strains; Receptors, Muscarinic; Receptors, Nicotinic; Species Specificity | 1986 |
Fourth ventricle effects of nicotine, 2-methylpiperidine and cytisine in dogs.
Topics: Alkaloids; Animals; Azocines; Blood Pressure; Body Temperature; Decerebrate State; Dogs; Electroencephalography; Heart Rate; Injections, Intraventricular; Nicotine; Pain Measurement; Piperidines; Pupil; Quinolizines; Receptors, Nicotinic; Stereoisomerism | 1986 |
Motor-stimulating properties of cisapride on isolated gastrointestinal preparations of the guinea pig.
Topics: Acetylcholine; Animals; Atropine; Cisapride; Dose-Response Relationship, Drug; Electric Stimulation; Female; Gastrointestinal Motility; Guinea Pigs; Hexamethonium Compounds; In Vitro Techniques; Intestinal Mucosa; Male; Methacholine Chloride; Methacholine Compounds; Metoclopramide; Muscle Contraction; Nicotine; Piperidines; Rats; Rats, Inbred Strains; Serotonin; Tetrodotoxin | 1985 |
Structure-activity relationships of some pyridine, piperidine, and pyrrolidine analogues for enhancing and inhibiting the binding of (+/-)-[3H]nicotine to the rat brain P2 preparation.
Topics: Acetylcholine; Animals; Binding Sites; Brain; Female; Nicotine; Piperidines; Pyridines; Pyrrolidines; Rats; Structure-Activity Relationship | 1985 |
Stereospecificity of 2-methylpiperidine binding to a nicotinic up-regulatory site in the rat brain P2 preparation.
Topics: Animals; Brain; Female; Nicotine; Piperidines; Rats; Rats, Inbred Strains; Stereoisomerism | 1985 |
A new source of anabasine.
Topics: Anabasine; Chromatography, Thin Layer; Nicotine; Piperidines; Plants, Medicinal | 1974 |
The effects of various "nicotine-like" agents in the cat superior cervical ganglion in situ.
Topics: Acetylcholine; Alkaloids; Animals; Azocines; Cats; Dextroamphetamine; Dimethylphenylpiperazinium Iodide; Dose-Response Relationship, Drug; Ganglia, Spinal; Hexamethonium Compounds; In Vitro Techniques; Lobeline; Neuromuscular Depolarizing Agents; Nicotine; Ouabain; Piperidines; Potassium Chloride; Pyridines; Quaternary Ammonium Compounds; Scopolamine; Sparteine; Tetrodotoxin; Tubocurarine | 1974 |
A re-investigation of evidence for cholinergic neuromuscular transmission in insects.
Topics: Acetylcholine; Animals; Glutamates; Insecta; Microscopy, Electron; Morpholines; Muscle Denervation; Neuromuscular Junction; Nicotine; Physostigmine; Piperidines; Pyridines; Pyrrolidines; Quaternary Ammonium Compounds; Stimulation, Chemical; Succinylcholine; Synaptic Transmission | 1970 |
[Effect of electrolytes on the extraction of nicotine and anabasine by means of organic solutions from acid and alkaline water solutions].
Topics: Electrolytes; Ganglionic Blockers; Nicotine; Piperidines; Solutions | 1966 |
[Isolation of nicotine and anabasine from the organs of poisoned animals].
Topics: Alkaloids; Animals; Dogs; Ganglionic Blockers; Nicotine; Piperidines | 1969 |
[Loss of nicotine and anabasine during their isolation from biological material].
Topics: Cadaver; Ganglionic Blockers; Nicotine; Piperidines; Sulfuric Acids; Water | 1970 |
Determination of piribenzil in urine containing a metabolite and dextropropoxyphene by an ion pair extraction method.
Topics: Benzilates; Choline; Dextropropoxyphene; Humans; Methods; Nicotine; Parasympatholytics; Photometry; Piperidines; Quaternary Ammonium Compounds; Solubility; Tryptamines; Tyramine | 1970 |
[Comparative evaluation of methods of isolation of nicotine and anabasine from biological material].
Topics: Cadaver; Ganglionic Blockers; Methods; Nicotine; Piperidines; Sulfuric Acids; Tissue Extracts | 1970 |
Quinuclidine analogs of tobacco alkaloids.
Topics: Alkaloids; Animals; Blood Pressure; Dogs; Heart Rate; Histamine H1 Antagonists; Methods; Nicotiana; Nicotine; Parasympatholytics; Piperidines; Plants, Toxic; Pyrrolidines; Quinuclidines | 1971 |
The reversal of experimental cardiac arrhythmias by indoramin (Wy 21901).
Topics: Amides; Anesthetics, Local; Animals; Arrhythmia, Sinus; Arrhythmias, Cardiac; Blood Pressure; Cats; Epinephrine; Female; Guinea Pigs; Halothane; Ileum; In Vitro Techniques; Indoles; Lidocaine; Male; Muscle Contraction; Nicotine; Ouabain; Piperidines; Procaine; Propranolol; Quinidine; Tachycardia; Ventricular Fibrillation | 1971 |
Loperamide (R 18 553), a novel type of antidiarrheal agent. Part 3: in vitro studies on the peristaltic reflex and other experiments on isolated tissues.
Topics: Amides; Animals; Antidiarrheals; Cats; Cecum; Chickens; Chlorobenzenes; Duodenum; Electric Stimulation; Gastrointestinal Agents; Gastrointestinal Motility; Guinea Pigs; Heart Rate; Histamine; Ileum; In Vitro Techniques; Isoproterenol; Muscle Contraction; Muscle Tonus; Muscle, Smooth; Nicotine; Papillary Muscles; Peristalsis; Piperidines; Rabbits; Rats; Spleen; Stomach | 1974 |
[Pharmacological differences in the hypothermia from nicotine and tertiary parasympathomimetics].
Topics: Amino Alcohols; Animals; Arecoline; Aza Compounds; Bis-Trimethylammonium Compounds; Body Temperature; Bridged-Ring Compounds; Depression, Chemical; Dose-Response Relationship, Drug; Drug Antagonism; Ganglionic Stimulants; Methylamines; Mice; Nicotine; Norepinephrine; Oxotremorine; Parasympathomimetics; Piperidines; Propylamines; Spiro Compounds; Succinimides | 1972 |
Circular dichroic determination of the preferred conformation of nicotine and related chiral alkaloids in aqueous solution.
Topics: Alkaloids; Benzene; Circular Dichroism; Energy Transfer; Flavonoids; Models, Chemical; Molecular Conformation; Nicotine; Optical Rotatory Dispersion; Piperidines; Potentiometry; Pyridines; Solutions; Spectrophotometry, Ultraviolet | 1973 |
Comparative in vitro hepatic metabolism of some tertiary N-methyl tobacco alkaloids in various species.
Topics: Alkaloids; Animals; Chromatography, Gas; Chromatography, Paper; Cricetinae; Cyclic N-Oxides; Dealkylation; Female; Guinea Pigs; In Vitro Techniques; Liver; Male; Methylation; Mice; Nicotiana; Nicotine; Oxidation-Reduction; Piperidines; Plants, Toxic; Pyridines; Pyrroles; Rabbits; Rats; Species Specificity; Stereoisomerism; Time Factors | 1973 |
Studies on the action of some cholinoceptor agonists on the chick biventer cervicis muscle preparation.
Topics: Acetylcholine; Animals; Carbachol; Chickens; Choline; Cyclohexanols; Decamethonium Compounds; Dimethylphenylpiperazinium Iodide; Dose-Response Relationship, Drug; Electric Stimulation; Ganglionic Stimulants; In Vitro Techniques; Muscle Contraction; Neuromuscular Depolarizing Agents; Neuromuscular Junction; Nicotine; Parasympathomimetics; Physostigmine; Piperidines; Quaternary Ammonium Compounds | 1973 |
Structural requirements for nicotine and cyclic imine-induced amine release from neoplastic mast cells.
Topics: Amines; Animals; Azetines; Azirines; Cell Line; Chemical Phenomena; Chemistry; Electrons; Hydrogen-Ion Concentration; Imidazoles; Imines; Kinetics; Mast Cells; Mice; Mice, Inbred Strains; Neoplasms; Nicotine; Piperidines; Pyrroles; Pyrrolidines; Serotonin; Solubility; Spectrometry, Fluorescence; Structure-Activity Relationship | 1974 |
Correlation of chick embryo teratogenicity with the nicotinic activity of a series of tetrahydropyrimidines.
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Animals; Azepines; Chick Embryo; Hindlimb; Imidazoles; Neuromuscular Junction; Nicotine; Piperidines; Pyridines; Pyrimidines; Spine; Structure-Activity Relationship | 1972 |
Pharmacological studies on alicyclic amines. I. Comparison of pharmacological activities of piperidine with those of other amines.
Topics: Adrenal Glands; Amines; Animals; Anura; Blood Pressure; Cats; Dogs; Female; Ganglia; Ganglia, Autonomic; Heart; Hexamethonium Compounds; Ileum; In Vitro Techniques; Male; Mice; Neuromuscular Junction; Nicotine; Nictitating Membrane; Parasympatholytics; Piperidines; Procaine; Pyrrolidines; Reserpine; Respiration | 1967 |
[Pharmacological studies of 2-(1-piperidino)-ethyl benzilate ethylbromide (PB-106)].
Topics: Acetylcholine; Animals; Anura; Atropine; Barium; Benzilates; Blood Glucose; Blood Pressure; Blood Vessels; Bromides; Cats; Dogs; Female; Gastric Juice; Guinea Pigs; Heart; Hexamethonium Compounds; Histamine Antagonists; In Vitro Techniques; Intestines; Male; Mice; Nicotine; Nictitating Membrane; Pilocarpine; Piperidines; Rabbits; Rats; Regional Blood Flow; Saliva; Scopolamine; Seminal Vesicles; Tranquilizing Agents; Ureter; Urinary Bladder | 1969 |
2-methyl-3-(4-phenylpiperidino)propionohydroxamic acid hydrochloride--a new hypotensive agent.
Topics: Acetylcholine; Animals; Atropine; Blood Pressure; Carotid Artery Diseases; Cats; Drug Synergism; Epinephrine; Female; Ganglia, Autonomic; Heart Rate; Hydroxamic Acids; Ileum; Male; Muscle Contraction; Nicotine; Nictitating Membrane; Pentolinium Tartrate; Piperidines; Propionates | 1970 |
Ligand-binding properties of an unusual nicotinic acetylcholine receptor subtype on isolated outer hair cells from guinea pig cochlea.
Topics: Animals; Atropine; Binding, Competitive; Bungarotoxins; Cochlea; Female; Guinea Pigs; Hair Cells, Auditory, Outer; In Vitro Techniques; Ligands; Male; Muscarinic Antagonists; Nicotine; Parasympatholytics; Piperidines; Quinuclidinyl Benzilate; Radioligand Assay; Receptors, Nicotinic; Strychnine | 1995 |
A single transmitter regulates gene expression through two separate mechanisms: cholinergic regulation of phenylethanolamine N-methyltransferase mRNA via nicotinic and muscarinic pathways.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Acetylcholine; Adrenal Medulla; Animals; Atropine; Binding, Competitive; Calcimycin; Calcium; Carbachol; Cattle; Cells, Cultured; Colforsin; Epinephrine; Gene Expression Regulation, Enzymologic; Hexamethonium; Hexamethonium Compounds; Kinetics; Muscarine; Nicotine; Phenylethanolamine N-Methyltransferase; Piperidines; Quinuclidinyl Benzilate; Receptors, Muscarinic; Receptors, Nicotinic; RNA, Messenger | 1994 |
In vitro pharmacologic characterization of a cholinergic receptor on outer hair cells.
Topics: Acetylcholine; Alkaloids; Animals; Atropine; Azocines; Bungarotoxins; Carbachol; Choline; Cholinergic Antagonists; Curare; Dimethylphenylpiperazinium Iodide; Guinea Pigs; Hair Cells, Auditory, Outer; In Vitro Techniques; Membrane Potentials; Nicotine; Piperidines; Pirenzepine; Quinolizines; Receptors, Cholinergic; Strychnine; Trimethaphan | 1994 |
Effect of coniine on the developing chick embryo.
Topics: Alkaloids; Animals; Arthrogryposis; Cerebral Hemorrhage; Chick Embryo; Nicotine; Piperidines; Teratogens | 1994 |
Cholinergic regulation of hippocampal brain-derived neurotrophic factor mRNA expression: evidence from lesion and chronic cholinergic drug treatment studies.
Topics: Acetylcholine; Acetylcholinesterase; Animals; Atropine; Blotting, Northern; Brain; Brain-Derived Neurotrophic Factor; Female; Gene Expression Regulation; Hippocampus; Nerve Growth Factors; Nerve Tissue Proteins; Neuromuscular Depolarizing Agents; Nicotine; Piperidines; Pyramidal Tracts; Rats; Rats, Wistar; RNA, Messenger; Stereotaxic Techniques | 1993 |
Enantiospecific inhibition of emesis induced by nicotine in the house musk shrew (Suncus murinus) by the neurokinin1 (NK1) receptor antagonist CP-99,994.
Topics: Animals; Antiemetics; Dose-Response Relationship, Drug; Indoles; Isoindoles; Male; Morphine; Neurokinin A; Nicotine; Piperidines; Receptors, Neurokinin-1; Shrews; Stereoisomerism; Substance P; Vomiting | 1995 |
The pharmacology of the emetic response to upper gastrointestinal tract stimulation in Suncus murinus.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Digestive System Physiological Phenomena; Diterpenes; Granisetron; Male; Morphine; Motion; Neurokinin-1 Receptor Antagonists; Nicotine; Piperidines; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Serotonin Receptor Agonists; Shrews; Vomiting | 1996 |
Reduction of the pressor response to nicotine in the guinea pigs by a histamine (H3) agonist is attenuated by an inhibitor of nitric oxide synthesis.
Topics: Adrenalectomy; Animals; Arginine; Blood Pressure; Cimetidine; Guinea Pigs; Heart Rate; Histamine; Histamine Agonists; Histamine Antagonists; Male; Methylhistamines; NG-Nitroarginine Methyl Ester; Nicotine; Nitric Oxide Synthase; Piperidines | 1996 |
Neuropharmacological characterization of basal forebrain cholinergic stimulated cataplexy in narcoleptic canines.
Topics: (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; Acetylcholine; Animals; Atropine; Behavior, Animal; Carbachol; Cataplexy; Cholinergic Fibers; Dogs; Feeding Behavior; Female; GABA Agonists; Gallamine Triethiodide; Male; Microdialysis; Muscarinic Agonists; Muscarinic Antagonists; Muscimol; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Oxotremorine; Piperidines; Pirenzepine; Prosencephalon | 1998 |
Activation of neurons in rat trigeminal subnucleus caudalis by different irritant chemicals applied to oral or ocular mucosa.
Topics: Alkaloids; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzodioxoles; Capsaicin; Conjunctiva; Cornea; Dose-Response Relationship, Drug; Electrophysiology; Ethanol; Ganglionic Stimulants; Histamine; Irritants; Male; Mouth Mucosa; Mustard Plant; Neurons; Nicotine; Piperidines; Plant Extracts; Plant Oils; Polyunsaturated Alkamides; Rats; Rats, Wistar; Reaction Time; Serotonin; Sodium Chloride; Solvents; Stimulation, Chemical; Tachyphylaxis; Tongue; Trigeminal Nuclei | 1998 |
5-HT4 receptor antagonism does not affect motor and reward mechanisms in the rat.
Topics: Amphetamine; Animals; Behavior, Animal; Cocaine; Dioxanes; Hyperkinesis; Male; Motor Activity; Nicotine; Piperidines; Rats; Rats, Sprague-Dawley; Self Stimulation; Serotonin Antagonists | 1998 |
Regulation of the choline transport system in superfused microcarrier cultures of BeWo cells.
Topics: Bethanechol; Biological Transport; Choline; Choriocarcinoma; Drug Carriers; Female; Hemicholinium 3; Humans; Microvilli; Naphthalenes; Neostigmine; Nicotine; Physostigmine; Piperidines; Quaternary Ammonium Compounds; Trophoblasts; Tumor Cells, Cultured; Uterine Neoplasms | 1998 |
Conformationally restricted analogues of nicotine and anabasine.
Topics: Anabasine; Animals; Antiparkinson Agents; Calcium; Cell Line; Cholinergic Agonists; Drug Design; Humans; Macromolecular Substances; Molecular Conformation; Neurons; Nicotine; Parkinson Disease, Secondary; Piperidines; Pyridines; Recombinant Proteins; Structure-Activity Relationship; Transfection | 1998 |
Inhibition of emesis by tachykinin NK1 receptor antagonists in Suncus murinus (house musk shrew).
Topics: Animals; Antiemetics; Copper Sulfate; Dipeptides; Dose-Response Relationship, Drug; Emetics; Female; Ganglionic Stimulants; Indoles; Infusions, Parenteral; Isoindoles; Male; Motion Sickness; Neurokinin-1 Receptor Antagonists; Nicotine; Physalaemin; Piperidines; Shrews; Stereoisomerism; Vomiting | 1999 |
Oral irritant properties of piperine and nicotine: psychophysical evidence for asymmetrical desensitization effects.
Topics: Adult; Alkaloids; Benzodioxoles; Female; Humans; Irritants; Male; Nicotine; Piperidines; Polyunsaturated Alkamides; Psychophysics; Tongue | 1999 |
Effect of cholinergic drugs on the concentration of intracellular free calcium of rat pituitary intermediate lobe cells.
Topics: (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; Acetylcholine; Age Factors; Animals; Atropine; Calcium; Carbachol; Cells, Cultured; Cholinergic Agonists; Cytosol; Female; Male; Melanocytes; Muscarine; Muscarinic Agonists; Muscarinic Antagonists; Nicotine; Nicotinic Agonists; Piperidines; Pirenzepine; Pituitary Gland; Rats; Rats, Wistar; Vasodilator Agents | 1999 |
Autoradiographic comparison of [3H](-)nicotine, [3H]cytisine and [3H]epibatidine binding in relation to vesicular acetylcholine transport sites in the temporal cortex in Alzheimer's disease.
Topics: Acetylcholine; Age Factors; Aged; Aged, 80 and over; Alkaloids; Alzheimer Disease; Autoradiography; Azocines; Bridged Bicyclo Compounds, Heterocyclic; Carrier Proteins; Female; Humans; Male; Membrane Transport Proteins; Middle Aged; Nicotine; Piperidines; Pyridines; Quinolizines; Reference Values; Temporal Lobe; Tritium; Vesicular Acetylcholine Transport Proteins; Vesicular Transport Proteins | 1999 |
The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Acoustic Stimulation; Animals; Body Temperature; Columbidae; Corticosterone; Depression; Discrimination Learning; Drug Interactions; Fluoxetine; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Lip; Male; Microdialysis; Neurons; Nicotine; Piperidines; Posture; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Reflex, Startle; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Smoking Cessation; Substance Withdrawal Syndrome; Sulfur Radioisotopes | 2000 |
The emetic and anti-emetic effects of the capsaicin analogue resiniferatoxin in Suncus murinus, the house musk shrew.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Abdomen; Animals; Animals, Newborn; Antiemetics; Behavior, Animal; Capsaicin; Cisplatin; Copper Sulfate; Diterpenes; Dose-Response Relationship, Drug; Female; Indoles; Injections, Intraventricular; Male; Medulla Oblongata; Morphine; Motion Sickness; Nicotine; Piperidines; Proto-Oncogene Proteins c-fos; Serotonin Receptor Agonists; Shrews; Tropisetron; Vagotomy; Vomiting | 2000 |
Synthesis of two conformationally constrained analogues of the minor tobacco alkaloid anabasine.
Topics: Acylation; Alkaloids; Anabasine; Catalysis; Cyclization; Nicotiana; Nicotine; Palladium; Piperidines; Plants, Toxic; Spiro Compounds; Stereoisomerism | 2000 |
Repetitive nerve stimulation decreases the acetylcholine content of quanta at the frog neuromuscular junction.
Topics: Acetylcholine; Animals; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cholinergic Agents; Cholinesterase Inhibitors; Dimethylphenylpiperazinium Iodide; Electric Stimulation; Hemicholinium 3; Membrane Potentials; Motor Neurons; Neostigmine; Neuromuscular Depolarizing Agents; Neuromuscular Junction; Nicotine; Nicotinic Agonists; Patch-Clamp Techniques; Piperidines; Rana pipiens; Synaptic Vesicles; Uncoupling Agents | 2001 |
2-(2-Piperidyl)- and 2-(2-pyrrolidyl)chromans as nicotine agonists: synthesis and preliminary pharmacological characterization.
Topics: Acetylcholine; Animals; Cerebral Cortex; Chromans; Cloning, Molecular; Corpus Striatum; Crystallography, X-Ray; Dopamine; Humans; In Vitro Techniques; Nicotine; Nicotinic Agonists; Oocytes; Piperidines; Pyrrolidines; Radioligand Assay; Rats; Receptors, Nicotinic; Structure-Activity Relationship; Synaptosomes; Xenopus laevis | 2001 |
SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats.
Topics: Animals; Brain Chemistry; Central Nervous System Depressants; Discrimination Learning; Dopamine; Ethanol; Extracellular Space; Male; Microdialysis; Motivation; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Nucleus Accumbens; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Reinforcement, Psychology; Rimonabant; Self Administration | 2002 |
Cognitive enhancing properties and tolerability of cholinergic agents in mice: a comparative study of nicotine, donepezil, and SIB-1553A, a subtype-selective ligand for nicotinic acetylcholine receptors.
Topics: Age Factors; Animals; Attention; Behavior, Animal; Choice Behavior; Cholinesterase Inhibitors; Cognition; Discrimination Learning; Donepezil; Dose-Response Relationship, Drug; Drug Interactions; Drug Tolerance; Indans; Lethal Dose 50; Male; Mecamylamine; Memory, Short-Term; Mice; Mice, Inbred C57BL; Motor Activity; Muscarinic Antagonists; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Phenols; Piperidines; Psychomotor Performance; Pyrrolidines; Reaction Time; Receptors, Nicotinic; Scopolamine; Seizures | 2003 |
[Antagonism of nicotinic substances among themselves; relation between their toxicity and their ganglion blocking activity].
Topics: Autonomic Agents; Ganglia, Autonomic; Lobeline; Nicotine; Phenethylamines; Piperidines; Procaine | 1953 |
Pharmacological properties of pempidine (1:2:2:6:6-pentamethylpiperidine), a new ganglion-blocking compound.
Topics: Animals; Autonomic Agents; Cats; Ganglia; Guinea Pigs; Mice; Nicotine; Nictitating Membrane; Pempidine; Piperidines | 1958 |
Interaction between histamine and dichloroisoproterenol, hexamethonium, pempidine, and diphenhydramine, in normal and reserpine-treated heart preparations.
Topics: Diphenhydramine; Ganglionic Blockers; Guinea Pigs; Heart; Hexamethonium; Hexamethonium Compounds; Histamine; Isoproterenol; Myocardium; Nicotine; Pempidine; Piperidines; Reserpine; Sympatholytics | 1960 |
EXPERIMENTS IN THE SWEATING ON THE PALMS OF THE GREEN MONKEY (CERCOPITHECUS AETHIOPS).
Topics: Acetylcholinesterase; Animals; Chlorocebus aethiops; Cholinesterases; Denervation; Epinephrine; Hand; Haplorhini; Methacholine Compounds; Nicotine; Pharmacology; Piperidines; Research; Sweat Glands; Sweating | 1964 |
RESPONSES OF THE RAT URINARY BLADDER IN SITU TO DRUGS AND TO NERVE STIMULATION.
Topics: Acetylcholine; Atropine; Epinephrine; Ganglionic Blockers; Histamine; Injections, Intravenous; Methysergide; Morphine; Muscle Contraction; Muscle, Smooth; Muscles; Neostigmine; Nicotine; Norepinephrine; Pharmacology; Physostigmine; Piperazines; Piperidines; Rats; Research; Scopolamine; Serotonin; Urinary Bladder; Vagus Nerve | 1965 |
Effects of donepezil on DOI-induced head twitch response in mice: implications for Tourette syndrome.
Topics: Amphetamines; Animals; Donepezil; Drug Synergism; Head Movements; Indans; Male; Mecamylamine; Mice; Mice, Inbred ICR; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Nootropic Agents; Piperidines; Serotonin Receptor Agonists; Tics; Time Factors; Tourette Syndrome | 2003 |
Donepezil modulates nicotinic receptors of substantia nigra dopaminergic neurones.
Topics: Animals; Cholinesterase Inhibitors; Donepezil; Dopamine; Electrophysiology; In Vitro Techniques; Indans; Insecticides; Membrane Potentials; Neurons; Nicotine; Nicotinic Agonists; Nootropic Agents; Organothiophosphorus Compounds; Patch-Clamp Techniques; Piperidines; Rats; Receptors, Nicotinic; Substantia Nigra; Synapses; Synaptic Transmission | 2004 |
Intraportal nicotine infusion in rats decreases hepatic blood flow through endothelin-1 and both endothelin A and endothelin B receptors.
Topics: Animals; Antibodies, Monoclonal; Azepines; Blood Pressure; Dose-Response Relationship, Drug; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; Heart Rate; Infusions, Intravenous; Laser-Doppler Flowmetry; Liver; Liver Circulation; Male; Nicotine; Nicotinic Agonists; Oligopeptides; Piperidines; Portal Vein; Rats; Rats, Wistar; Receptor, Endothelin A; Receptor, Endothelin B | 2004 |
The NR2B-selective N-methyl-D-aspartate receptor antagonist Ro 25-6981 [(+/-)-(R*,S*)-alpha-(4-hydroxyphenyl)-beta-methyl-4-(phenylmethyl)-1-piperidine propanol] potentiates the effect of nicotine on locomotor activity and dopamine release in the nucleus
Topics: 2-Amino-5-phosphonovalerate; Animals; Dizocilpine Maleate; Dopamine; Drug Synergism; Male; Microdialysis; Motor Activity; Nicotine; Nucleus Accumbens; Phenols; Piperidines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate | 2004 |
Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB1) receptor antagonist, rimonabant (SR141716).
Topics: Acoustic Stimulation; Animals; Cues; Dopamine; Environment; Extinction, Psychological; Light; Male; Motivation; Motor Activity; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; Self Administration; Substance Withdrawal Syndrome; Synaptic Transmission; Tobacco Use Disorder | 2005 |
The 5-HT receptor antagonist M100,907 prevents extracellular glutamate rising in response to NMDA receptor blockade in the mPFC.
Topics: 2-Amino-5-phosphonovalerate; Analysis of Variance; Animals; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Extracellular Space; Fluorobenzenes; Glutamic Acid; Male; Microdialysis; Nicotine; Piperazines; Piperidines; Potassium Chloride; Prefrontal Cortex; Rats; Receptor, Serotonin, 5-HT2A; Receptors, N-Methyl-D-Aspartate; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Tetrodotoxin | 2004 |
Toxicity of alkaloids for certain bacteria; coniine, nicotine, and strychnine.
Topics: Alkaloids; Bacteria; Humans; Nicotine; Piperidines; Solanine; Strychnine | 1949 |
Methamidophos transiently inhibits neuronal nicotinic receptors of rat substantia nigra dopaminergic neurons via open channel block.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Agonists; Excitatory Postsynaptic Potentials; In Vitro Techniques; Ion Channel Gating; Membrane Potentials; Neural Inhibition; Neuromuscular Depolarizing Agents; Neurons; Nicotine; Organothiophosphorus Compounds; Patch-Clamp Techniques; Piperidines; Rats; Rats, Wistar; Receptors, Nicotinic; Substantia Nigra | 2004 |
Rimonabant, a CB1 antagonist, blocks nicotine-conditioned place preferences.
Topics: Animals; Behavior, Animal; Conditioning, Operant; Dose-Response Relationship, Drug; Drug Interactions; Male; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Reinforcement, Psychology; Rimonabant | 2004 |
Anatalline and other methyl jasmonate-inducible nicotine alkaloids from Nicotiana tabacum cv. By-2 cell cultures.
Topics: Acetates; Alkaloids; Cells, Cultured; Chromatography, High Pressure Liquid; Cyclopentanes; Gas Chromatography-Mass Spectrometry; Humans; Magnetic Resonance Spectroscopy; Nicotiana; Nicotine; Oxylipins; Phytotherapy; Piperidines; Plant Leaves; Pyridines | 2004 |
Enhancement of purinergic neurotransmission by galantamine and other acetylcholinesterase inhibitors in the rat vas deferens.
Topics: Acetylcholine; Acetylcholinesterase; Animals; Cholinesterase Inhibitors; Donepezil; Drug Synergism; Electric Stimulation; Galantamine; In Vitro Techniques; Indans; Male; Muscle Contraction; Muscle, Smooth; Nicotine; Nicotinic Agonists; Phenylcarbamates; Physostigmine; Piperidines; Rats; Rats, Wistar; Receptors, Purinergic; Rivastigmine; Stimulation, Chemical; Synaptic Transmission; Tacrine; Vas Deferens | 2004 |
Suppression of conditioned nicotine and sucrose seeking by the cannabinoid-1 receptor antagonist SR141716A.
Topics: Animals; Behavior, Animal; Cannabinoid Receptor Antagonists; Conditioning, Operant; Dose-Response Relationship, Drug; Drug Interactions; Extinction, Psychological; Inhibition, Psychological; Male; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Rats; Rats, Wistar; Rimonabant; Sucrose; Sweetening Agents | 2005 |
Cannabinoid CB1 receptors are involved in motivational effects of nicotine in rats.
Topics: Animals; Association Learning; Conditioning, Psychological; Dose-Response Relationship, Drug; Injections, Subcutaneous; Male; Motivation; Nicotine; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant | 2005 |
[Medication for ending tobacco dependency. Current state].
Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Cannabinoid Receptor Antagonists; Humans; Nicotine; Piperidines; Pyrazoles; Quinoxalines; Receptors, Nicotinic; Rimonabant; Smoking Cessation; Time Factors; Tobacco Use Disorder; Varenicline | 2005 |
Effects of donepezil, nicotine and haloperidol on the central serotonergic system in mice: implications for Tourette's syndrome.
Topics: Amphetamines; Animals; Behavior, Animal; Binding, Competitive; Cerebral Cortex; Corpus Striatum; Donepezil; Dose-Response Relationship, Drug; Frontal Lobe; Gene Expression; Haloperidol; Humans; Indans; Ketanserin; Male; Mesencephalon; Mice; Mice, Inbred ICR; Nicotine; Piperidines; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Serotonin Antagonists; Tourette Syndrome | 2005 |
Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors.
Topics: Aconitine; Amyloid beta-Peptides; Apoptosis; Benzopyrans; Cell Culture Techniques; Cell Line, Tumor; Cholinesterase Inhibitors; Chromones; Donepezil; Dose-Response Relationship, Drug; Enzyme Inhibitors; Galantamine; Humans; Indans; L-Lactate Dehydrogenase; Morpholines; Neuroblastoma; Neuroprotective Agents; Nicotine; Nitriles; Okadaic Acid; Phenylcarbamates; Phosphatidylinositol 3-Kinases; Piperidines; Proto-Oncogene Proteins c-bcl-2; Receptors, Nicotinic; Rivastigmine | 2005 |
In vivo characterization of a novel inhibitor of CNS nicotinic receptors.
Topics: Analgesics; Animals; Body Temperature; Central Nervous System; Discrimination, Psychological; Dose-Response Relationship, Drug; Heptanoic Acids; Male; Mice; Mice, Inbred ICR; Motor Activity; Nicotine; Pain; Pain Measurement; Piperidines; Rats; Rats, Long-Evans; Receptors, Nicotinic; Time Factors | 2005 |
Role of the cannabinoid system in the effects induced by nicotine on anxiety-like behaviour in mice.
Topics: Animals; Arousal; Conditioning, Classical; Dose-Response Relationship, Drug; Dronabinol; Fear; Male; Maze Learning; Mice; Nicotine; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant | 2006 |
Suppression of methamphetamine-seeking behavior by nicotinic agonists.
Topics: Acetylcholinesterase; Animals; Behavior, Animal; Brain; Cholinesterase Inhibitors; Donepezil; Indans; Lidocaine; Male; Mecamylamine; Methamphetamine; Nicotine; Nicotinic Agonists; Piperidines; Rats; Rats, Wistar; Receptors, Nicotinic; Scopolamine | 2006 |
Nicotine, donepezil may dampen meth craving.
Topics: Amphetamine-Related Disorders; Animals; Central Nervous System Agents; Donepezil; Humans; Indans; Methamphetamine; Nicotine; Piperidines | 2006 |
Differential involvement of the endocannabinoid system in short- and long-term expression of incentive learning supported by nicotine in rats.
Topics: Animals; Association Learning; Autoradiography; Behavior, Animal; Benzoxazines; Binding, Competitive; Brain; Cannabinoid Receptor Modulators; Conditioning, Classical; Endocannabinoids; Guanosine 5'-O-(3-Thiotriphosphate); Male; Morpholines; Motivation; Motor Activity; Naphthalenes; Neuronal Plasticity; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant; Time Factors | 2006 |
WIN-55,212-2 and SR-141716A alter nicotine-induced changes in locomotor activity, but do not alter nicotine-evoked [3H]dopamine release.
Topics: Analgesics; Animals; Benzoxazines; Cannabinoid Receptor Antagonists; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Drug Antagonism; In Vitro Techniques; Male; Morpholines; Motor Activity; Naphthalenes; Nicotine; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Rimonabant; Tritium | 2007 |
The CB1 cannabinoid receptor antagonist rimonabant chronically prevents the nicotine-induced relapse to alcohol.
Topics: Alcohol-Induced Disorders, Nervous System; Alcoholism; Animals; Anxiety Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Synergism; Male; Maze Learning; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Reinforcement, Psychology; Rimonabant; Secondary Prevention; Substance Withdrawal Syndrome; Sucrose | 2007 |
Genetic and pharmacological approaches to evaluate the interaction between the cannabinoid and cholinergic systems in cognitive processes.
Topics: Animals; Avoidance Learning; Cognition; Male; Mice; Mice, Knockout; Nicotine; Physostigmine; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptors, Nicotinic; Rimonabant; Scopolamine | 2007 |
Interaction of nicotinic and histamine H(3) systems in the radial-arm maze repeated acquisition task.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Anticonvulsants; Behavior, Animal; Dose-Response Relationship, Drug; Female; Histamine Antagonists; Injections, Subcutaneous; Maze Learning; Nicotine; Nicotinic Agonists; Piperidines; Protein Binding; Rats; Rats, Sprague-Dawley; Reaction Time; Receptor Cross-Talk; Receptors, Histamine H3; Receptors, Nicotinic; Reinforcement, Psychology | 2007 |
Cortico-limbic circuitry for conditioned nicotine-seeking behavior in rats involves endocannabinoid signaling.
Topics: Amygdala; Animals; Behavior, Addictive; Cannabinoid Receptor Modulators; Cerebral Cortex; Conditioning, Operant; Cues; Dose-Response Relationship, Drug; Endocannabinoids; Ganglionic Stimulants; Injections, Intravenous; Injections, Intraventricular; Limbic System; Male; Models, Anatomic; Motor Activity; Nicotine; Nucleus Accumbens; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Rimonabant; Self Administration; Signal Transduction; Time Factors | 2007 |
Effects of the serotonin 5-HT2A and 5-HT2C receptor ligands on the discriminative stimulus effects of nicotine in rats.
Topics: Aminopyridines; Amphetamines; Animals; Azepines; Azetidines; Behavior, Animal; Brain; Discrimination, Psychological; Dose-Response Relationship, Drug; Ethylamines; Fluorobenzenes; Indoles; Ligands; Male; Nicotine; Nicotinic Agonists; Piperidines; Pyridines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Nicotinic; Serotonin 5-HT2 Receptor Agonists; Serotonin Antagonists; Serotonin Receptor Agonists | 2007 |
Cholinergic drugs affect novel object recognition in rats: relation with hippocampal EEG?
Topics: Animals; Cholinergic Agents; Cholinesterase Inhibitors; Donepezil; Electroencephalography; Evoked Potentials, Auditory; Exploratory Behavior; Hippocampus; Indans; Male; Memory; Nicotine; Nicotinic Agonists; Piperidines; Rats; Rats, Wistar; Recognition, Psychology; Scopolamine | 2007 |
Effects of adolescent nicotine and SR 147778 (Surinabant) administration on food intake, somatic growth and metabolic parameters in rats.
Topics: Age Factors; Analysis of Variance; Animals; Animals, Newborn; Behavior, Animal; Blood Glucose; Body Weight; Cholesterol, HDL; Disease Models, Animal; Eating; Enzyme-Linked Immunosorbent Assay; Female; Hormones; Lipid Metabolism; Male; Nicotine; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Sex Factors; Substance Withdrawal Syndrome | 2008 |
Rimonabant blocks the expression but not the development of locomotor sensitization to nicotine in rats.
Topics: Analysis of Variance; Animals; Body Weight; Cues; Injections, Intraperitoneal; Male; Motor Activity; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Rats; Rats, Long-Evans; Receptor, Cannabinoid, CB1; Rimonabant | 2008 |
Cholinergic innervation of the guinea-pig isolated vas deferens.
Topics: Acetylcholine; Adrenergic alpha-Antagonists; Animals; Bretylium Compounds; Calcium; Cholinesterase Inhibitors; Cyclopentolate; Guinea Pigs; In Vitro Techniques; Male; Muscarinic Antagonists; Muscle Contraction; Myocytes, Smooth Muscle; Neostigmine; Nicotine; Nicotinic Agonists; Piperidines; Receptors, Muscarinic; Vas Deferens; Yohimbine | 2007 |
The cannabinoid antagonist AM251 attenuates nicotine self-administration and nicotine-seeking behaviour in rats.
Topics: Animals; Cannabinoids; Conditioning, Operant; Cues; Dose-Response Relationship, Drug; Food; Male; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Rats; Reinforcement, Psychology; Secondary Prevention; Self Administration; Tobacco Use Disorder | 2008 |
Smoking cessation 2008.
Topics: Benzazepines; Cannabinoid Receptor Antagonists; Drug Prescriptions; Humans; Marketing of Health Services; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Quinoxalines; Rimonabant; Smoking; Smoking Cessation; Smoking Prevention; Vaccines; Varenicline | 2008 |
The endogenous cannabinoid system modulates nicotine reward and dependence.
Topics: Animals; Cannabinoid Receptor Modulators; Conditioning, Psychological; Female; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nicotine; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Reward; Rimonabant; Signal Transduction; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2008 |
Cannabinoid receptor ligands suppress memory-related effects of nicotine in the elevated plus maze test in mice.
Topics: Animals; Behavior, Animal; Benzoxazines; Calcium Channel Blockers; Cannabinoid Receptor Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Maze Learning; Memory; Mice; Morpholines; Naphthalenes; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptors, Cannabinoid; Retention, Psychology | 2008 |
Contextual renewal of nicotine seeking in rats and its suppression by the cannabinoid-1 receptor antagonist Rimonabant (SR141716A).
Topics: Analysis of Variance; Animals; Behavior, Animal; Cannabinoid Receptor Antagonists; Conditioning, Operant; Extinction, Psychological; Male; Nicotine; Piperidines; Pyrazoles; Rats; Rats, Wistar; Reinforcement, Psychology; Rimonabant; Self Administration; Tobacco Use Disorder | 2008 |
Modulatory effects of histamine on cat carotid body chemoreception.
Topics: Acetylcholine; Action Potentials; Animals; Carotid Body; Cats; Chemoreceptor Cells; Dose-Response Relationship, Drug; Histamine; Histamine Agonists; Histamine H1 Antagonists; Histamine H3 Antagonists; Hypoxia; In Vitro Techniques; Male; Microscopy, Immunoelectron; Nicotine; Nicotinic Agonists; Piperidines; Pyrilamine; Tyrosine 3-Monooxygenase | 2008 |
Effects of a cannabinoid receptor (CB) 1 antagonist AM251 on behavioral sensitization to nicotine in a rat model of novelty-seeking behavior: correlation with hippocampal 5HT.
Topics: Animals; Behavior, Animal; Bupropion; Dose-Response Relationship, Drug; Exploratory Behavior; Hippocampus; Locomotion; Male; Microdialysis; Models, Animal; Nicotine; Nicotinic Agonists; Phenotype; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Serotonin; Smoking Cessation | 2009 |
Neuroprotective effects of donepezil through inhibition of GSK-3 activity in amyloid-beta-induced neuronal cell death.
Topics: Amyloid beta-Peptides; Analysis of Variance; Animals; Apoptosis; Cell Survival; Cells, Cultured; Cerebral Cortex; Cholinesterase Inhibitors; Chromones; Donepezil; Dose-Response Relationship, Drug; Embryo, Mammalian; Glycogen Synthase Kinase 3; Indans; Indoles; Mecamylamine; Morpholines; Neurons; Neuroprotective Agents; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Peptide Fragments; Phosphorylation; Piperidines; Rats; Rats, Sprague-Dawley; Serine; Sincalide | 2009 |
Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors.
Topics: Amides; Amidohydrolases; Animals; Appetite Depressants; Arachidonic Acids; Benzamides; Cannabinoid Receptor Antagonists; Carbamates; Dopamine; Endocannabinoids; Enzyme Activation; Enzyme Inhibitors; Ethanolamines; Injections, Intraventricular; Lipoxygenase Inhibitors; Male; Neurons; Nicotine; Oleic Acids; Organ Culture Techniques; Palmitic Acids; Patch-Clamp Techniques; Piperidines; PPAR alpha; Protein-Tyrosine Kinases; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Rimonabant; Ventral Tegmental Area | 2008 |
Chronic nicotine alters cannabinoid-mediated locomotor activity and receptor density in periadolescent but not adult male rats.
Topics: Adolescent; Aging; Analgesics; Animals; Cannabinoids; Cyclohexanols; Dronabinol; Female; Humans; Male; Motor Activity; Nicotine; Nicotinic Agonists; Piperidines; Psychotropic Drugs; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid | 2009 |
The FAAH inhibitor URB-597 interferes with cisplatin- and nicotine-induced vomiting in the Suncus murinus (house musk shrew).
Topics: Amidohydrolases; Animals; Arachidonic Acids; Benzamides; Carbamates; Cisplatin; Drug Interactions; Endocannabinoids; Female; Male; Nicotine; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Shrews; Vomiting | 2009 |
Interactions of serotonin (5-HT)2 receptor-targeting ligands and nicotine: locomotor activity studies in rats.
Topics: Aminopyridines; Analysis of Variance; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Fluorobenzenes; Indoles; Male; Motor Activity; Nicotine; Nicotinic Agonists; Piperidines; Rats; Rats, Wistar; Receptors, Serotonin, 5-HT2; Serotonin Antagonists; Serotonin Receptor Agonists; Time Factors | 2009 |
Effects of rimonabant on the reinstatement of nicotine-conditioned place preference by drug priming in rats.
Topics: Analysis of Variance; Animals; Central Nervous System Agents; Conditioning, Classical; Extinction, Psychological; Male; Morphine; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Random Allocation; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant; Spatial Behavior | 2009 |
Discriminative stimulus properties of delta9-tetrahydrocannabinol (THC) in C57Bl/6J mice.
Topics: Amidohydrolases; Animals; Arachidonic Acids; Discrimination Learning; Discrimination, Psychological; Dose-Response Relationship, Drug; Dronabinol; Endocannabinoids; Hallucinogens; Male; Mice; Mice, Inbred C57BL; Nicotine; Phenylmethylsulfonyl Fluoride; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant | 2009 |
Inhibition of fatty acid amide hydrolase reduces reinstatement of nicotine seeking but not break point for nicotine self-administration--comparison with CB(1) receptor blockade.
Topics: Amidohydrolases; Animals; Behavior, Addictive; Benzamides; Carbamates; Enzyme Inhibitors; Male; Nicotine; Piperidines; Pyrazoles; Rats; Rats, Long-Evans; Receptor, Cannabinoid, CB1; Rimonabant; Self Administration; Smoking | 2009 |
An increase in intracelluar free calcium ions modulated by cholinergic receptors in rat facial nucleus.
Topics: Acetylcholine; Aniline Compounds; Animals; Brain Stem; Calcium; Diamines; Facial Nerve; Female; Fluorescent Dyes; In Vitro Techniques; Male; Microscopy, Confocal; Motor Neurons; Muscarinic Agonists; Nicotine; Nicotinic Agonists; Piperidines; Pirenzepine; Rats; Rats, Sprague-Dawley; Receptors, Cholinergic; Receptors, Muscarinic; Receptors, Nicotinic; Tropicamide; Xanthenes | 2009 |
Investigation of endocannabinoid modulation of conditioned responding evoked by a nicotine CS and the Pavlovian stimulus effects of CP 55,940 in adult male rats.
Topics: Animals; Conditioning, Classical; Cyclohexanols; Discrimination Learning; Drug Interactions; Male; Nicotine; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant | 2009 |
[Current and future medical drugs for smoking cessation].
Topics: Adrenergic alpha-Agonists; Antidepressive Agents; Behavior Therapy; Benzazepines; Bupropion; Cannabinoid Receptor Antagonists; Clinical Trials as Topic; Clonidine; Combined Modality Therapy; Counseling; Humans; Nicotine; Nicotinic Agonists; Nortriptyline; Piperidines; Pyrazoles; Quinoxalines; Rimonabant; Smoking Cessation; Tobacco Use Disorder; Vaccines; Varenicline | 2009 |
Additive protective effects of donepezil and nicotine against salsolinol-induced cytotoxicity in SH-SY5Y cells.
Topics: Analysis of Variance; Annexin A5; Apoptosis; Atropine; Cell Cycle; Cell Line, Tumor; Cell Survival; Cholinesterase Inhibitors; Donepezil; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Indans; Mecamylamine; Neuroblastoma; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Piperidines; Propidium; Salsoline Alkaloids | 2009 |
Measurement of affective state during chronic nicotine treatment and withdrawal by affective taste reactivity in mice: the role of endocannabinoids.
Topics: Affect; Animals; Avoidance Learning; Cannabinoid Receptor Modulators; Endocannabinoids; Male; Mice; Mice, Inbred C57BL; Nicotine; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Substance Withdrawal Syndrome; Taste; Tobacco Use Disorder | 2009 |
Effects of the cannabinoid receptor ligands on anxiety-related effects of d-amphetamine and nicotine in the mouse elevated plus maze test.
Topics: Animals; Anxiety; Benzoxazines; Cannabinoid Receptor Agonists; Central Nervous System Stimulants; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Interactions; Ligands; Male; Maze Learning; Mice; Morpholines; Naphthalenes; Nicotine; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptors, Cannabinoid; Rimonabant | 2009 |
The role of nicotinic receptors in the amelioration of cholinesterase inhibitors in scopolamine-induced memory deficits.
Topics: Animals; Cholinesterase Inhibitors; Disease Models, Animal; Donepezil; Dose-Response Relationship, Drug; Drug Interactions; Hippocampus; Indans; Learning Disabilities; Male; Maze Learning; Mecamylamine; Muscarinic Agonists; Nicotine; Nicotinic Antagonists; Physostigmine; Pilocarpine; Piperidines; Rats; Rats, Wistar; Receptors, Nicotinic; Scopolamine; Theta Rhythm | 2009 |
Prosocial effects of nicotine and ethanol in adolescent rats through partially dissociable neurobehavioral mechanisms.
Topics: Aging; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Central Nervous System Depressants; Diazepam; Dopamine Antagonists; Ethanol; Exploratory Behavior; Flupenthixol; Locomotion; Male; Naloxone; Narcotic Antagonists; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant; Social Behavior | 2009 |
Association constants of pyridine and piperidine alkaloids to amyloid beta peptide determined by electrochemical impedance spectroscopy.
Topics: Alkaloids; Alzheimer Disease; Amyloid beta-Peptides; Binding, Competitive; Blood-Brain Barrier; Brain; Brain Chemistry; Electric Impedance; Electrochemistry; Electrodes; Humans; Microscopy; Nicotine; Peptide Fragments; Piperidines; Pyridines | 2010 |
Effect of administration of the nicotinic acetylcholine receptor antagonist BTMPS, during nicotine self-administration, on lever responding induced by context long after withdrawal.
Topics: Animals; Behavior, Animal; Body Weight; Conditioning, Operant; Decanoic Acids; Dose-Response Relationship, Drug; Feeding Behavior; Male; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Piperidines; Psychomotor Performance; Rats; Rats, Wistar; Reward; Self Administration; Space Perception; Time Factors; Tobacco Use Cessation | 2010 |
Inhibition of glycine transporter 1 attenuates nicotine- but not food-induced cue-potentiated reinstatement for a response previously paired with sucrose.
Topics: Analysis of Variance; Animals; Behavior, Addictive; Behavior, Animal; Benzamides; Conditioning, Operant; Cues; Dose-Response Relationship, Drug; Extinction, Psychological; Feeding Behavior; Food; Glycine Plasma Membrane Transport Proteins; Male; Mecamylamine; Nicotine; Nicotinic Antagonists; Piperidines; Rats; Rats, Wistar; Receptors, Nicotinic; Reinforcement Schedule; Reinforcement, Psychology; Self Administration; Sucrose | 2010 |
Novel bis-2,2,6,6-tetramethylpiperidine (bis-TMP) and bis-mecamylamine antagonists at neuronal nicotinic receptors mediating nicotine-evoked dopamine release.
Topics: Animals; Dopamine; Inhibitory Concentration 50; Mecamylamine; Molecular Structure; Nicotine; Nicotinic Antagonists; Piperidines; Rats; Receptors, Nicotinic | 2010 |
Mechanisms of chronic nicotine treatment-induced enhancement of the sensitivity of cortical neurons to the neuroprotective effect of donepezil in cortical neurons.
Topics: Animals; Cell Survival; Cells, Cultured; Cerebral Cortex; Donepezil; Drug Synergism; Indans; Neurons; Neuroprotective Agents; Nicotine; Piperidines; Rats; Rats, Wistar; Receptors, Nicotinic; Up-Regulation | 2010 |
Differential effects of serotonin (5-HT)2 receptor-targeting ligands on locomotor responses to nicotine-repeated treatment.
Topics: Aminopyridines; Amphetamines; Animals; Azepines; Ethylamines; Fluorobenzenes; Indoles; Male; Motor Activity; Nicotine; Nicotinic Agonists; Piperidines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists; Time Factors | 2010 |
Effect of the selective kappa-opioid receptor antagonist JDTic on nicotine antinociception, reward, and withdrawal in the mouse.
Topics: Analgesics; Animals; Anxiety; Buprenorphine; Dose-Response Relationship, Drug; Hyperalgesia; Hypothermia; Male; Mice; Morphine; Nicotine; Piperidines; Receptors, Opioid, kappa; Reward; Substance Withdrawal Syndrome; Tetrahydroisoquinolines | 2010 |
Second-order schedules of nicotine reinforcement in rats: effect of AM251.
Topics: Animals; Appetitive Behavior; Association Learning; Brain; Conditioning, Classical; Dopamine; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Male; Motivation; Nerve Net; Nicotine; Piperidines; Pyrazoles; Rats; Rats, Inbred Strains; Receptor, Cannabinoid, CB1; Reinforcement Schedule; Tobacco Use Disorder | 2010 |
A second-order schedule of food reinforcement in rats to examine the role of CB1 receptors in the reinforcement-enhancing effects of nicotine.
Topics: Animals; Appetitive Behavior; Association Learning; Brain; Conditioning, Classical; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Male; Motivation; Nicotine; Piperidines; Pyrazoles; Rats; Rats, Inbred Strains; Receptor, Cannabinoid, CB1; Reinforcement Schedule; Tobacco Use Disorder | 2010 |
Current treatment options in smoking cessation.
Topics: Adrenergic alpha-Agonists; Antidepressive Agents; Behavior Therapy; Benzazepines; Bupropion; Clonidine; Combined Modality Therapy; Counseling; Humans; Nicotine; Nicotinic Agonists; Nortriptyline; Patient Selection; Piperidines; Practice Guidelines as Topic; Pyrazoles; Quinoxalines; Rimonabant; Self-Help Groups; Smoking Cessation; Tobacco Use Disorder; United States; Vaccines; Varenicline | 2010 |
Alternative method of oral dosing for rats.
Topics: Administration, Oral; Animals; Behavior, Animal; Donepezil; Galantamine; Indans; Laboratory Animal Science; Male; Nicotine; Nootropic Agents; Piperidines; Rats; Recognition, Psychology; Stress, Physiological; Sucrose; Syringes; Time Factors | 2010 |
The alpha2 adrenergic receptor antagonist idazoxan, but not the serotonin-2A receptor antagonist M100907, partially attenuated reward deficits associated with nicotine, but not amphetamine, withdrawal in rats.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic Uptake Inhibitors; Amphetamine; Animals; Brain; Dihydro-beta-Erythroidine; Electrodes, Implanted; Fluorobenzenes; Ganglionic Stimulants; Idazoxan; Male; Nicotine; Piperidines; Rats; Rats, Wistar; Receptors, Nicotinic; Reward; Serotonin Antagonists; Substance Withdrawal Syndrome | 2010 |
An examination of NMDA receptor contribution to conditioned responding evoked by the conditional stimulus effects of nicotine.
Topics: 2-Amino-5-phosphonovalerate; Animals; Brain; Conditioning, Classical; Cyclopentanes; Discrimination, Psychological; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Male; Mecamylamine; N-Methylaspartate; Nicotine; Phencyclidine; Phenols; Piperazines; Piperidines; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate | 2011 |
One-pot formation of piperidine- and pyrrolidine-substituted pyridinium salts via addition of 5-alkylaminopenta-2,4-dienals to N-acyliminium ions: application to the synthesis of (±)-nicotine and analogs.
Topics: Acrylates; Alkylation; Amines; Imines; Ions; Molecular Structure; Nicotine; Piperidines; Pyridinium Compounds; Pyrrolidines | 2010 |
Histamine H(1) antagonist treatment with pyrilamine reduces nicotine self-administration in rats.
Topics: Animals; Butyrophenones; Drug Administration Schedule; Female; Follow-Up Studies; Food; Histamine; Histamine H1 Antagonists; Infusion Pumps; Injections; Motivation; Nicotine; Piperidines; Pyrilamine; Rats; Rats, Sprague-Dawley; Self Administration; Tobacco Use Disorder | 2011 |
Interactions between endocannabinoid and serotonergic systems in mood disorders caused by nicotine withdrawal.
Topics: Animals; Arachidonic Acids; Behavior, Animal; Cannabinoid Receptor Modulators; Disease Models, Animal; Drug Interactions; Endocannabinoids; Male; Mice; Mood Disorders; Motor Activity; Nicotine; Piperazines; Piperidines; Pyrazoles; Pyridines; Random Allocation; Receptor, Cannabinoid, CB1; Receptor, Serotonin, 5-HT1A; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Serotonin Antagonists; Smoking Cessation; Substance Withdrawal Syndrome | 2011 |
Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking.
Topics: Analgesics, Opioid; Animals; Behavior, Addictive; Behavior, Animal; Benzoxazines; Conditioning, Operant; Cues; Discrimination, Psychological; Dose-Response Relationship, Drug; Extinction, Psychological; Feeding Behavior; Male; Morpholines; Motivation; Motor Activity; Naphthalenes; Nicotine; Piperidines; Pyrazoles; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Reinforcement, Psychology; Rimonabant; Self Administration; Tobacco Use Disorder | 2012 |
ICV STZ induced impairment in memory and neuronal mitochondrial function: A protective role of nicotinic receptor.
Topics: Analysis of Variance; Animals; Blood Glucose; Brain; Calcium; Caspase 3; Cell Death; Cholinesterase Inhibitors; Disease Models, Animal; Donepezil; Glutathione; Indans; Injections, Intraventricular; Male; Malondialdehyde; Maze Learning; Memory Disorders; Mitochondria; Motor Activity; Neurons; Nicotine; Piperidines; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, Nicotinic; Streptozocin; Tacrine | 2011 |
Cannabinoid CB1 receptor antagonist rimonabant disrupts nicotine reward-associated memory in rats.
Topics: Animals; Avoidance Learning; Conditioning, Operant; Male; Memory; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Reward; Rimonabant | 2011 |
Differential effects of TRPV1 receptor ligands against nicotine-induced depression-like behaviors.
Topics: Animals; Antidepressive Agents; Arachidonic Acids; Capsaicin; Depression; Dopamine; Endocannabinoids; Hindlimb Suspension; Ligands; Male; Mice; Mice, Inbred ICR; Nicotine; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptor, Cannabinoid, CB1; Stress, Psychological; Swimming; TRPV Cation Channels | 2011 |
Dorsal hippocampal cannabinoid CB1 receptors mediate the interactive effects of nicotine and ethanol on passive avoidance learning in mice.
Topics: Amnesia; Analysis of Variance; Animals; Arachidonic Acids; Avoidance Learning; CA1 Region, Hippocampal; Drug Interactions; Ethanol; Male; Mental Recall; Mice; Microinjections; Nicotine; Piperidines; Pyrazoles; Random Allocation; Receptor, Cannabinoid, CB1 | 2013 |
Inhibitory inputs from rostromedial tegmental neurons regulate spontaneous activity of midbrain dopamine cells and their responses to drugs of abuse.
Topics: Action Potentials; Analysis of Variance; Animals; Benzoxazines; Cannabinoids; Cocaine; Dopaminergic Neurons; Electric Stimulation; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Male; Morphine; Morpholines; Naloxone; Naphthalenes; Narcotic Antagonists; Narcotics; Neural Inhibition; Neural Pathways; Nicotine; Nicotinic Agonists; Patch-Clamp Techniques; Physical Stimulation; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Rimonabant; Tegmentum Mesencephali; Time Factors; Ventral Tegmental Area | 2012 |
Effects of the 5-HT2C receptor agonist Ro60-0175 and the 5-HT2A receptor antagonist M100907 on nicotine self-administration and reinstatement.
Topics: Animals; Ethylamines; Fluorobenzenes; Indoles; Male; Nicotine; Piperidines; Rats; Rats, Long-Evans; Reaction Time; Self Administration; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists | 2012 |
Nicotine reinforcement is reduced by cannabinoid CB1 receptor blockade in the ventral tegmental area.
Topics: Animals; Cannabinoid Receptor Antagonists; Catheterization; Dose-Response Relationship, Drug; Drug-Seeking Behavior; Infusions, Intraventricular; Injections, Intraventricular; Nicotine; Nucleus Accumbens; Piperidines; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Reinforcement Schedule; Self Administration; Ventral Tegmental Area | 2013 |
Nicotine-induced anxiety-like behavior in a rat model of the novelty-seeking phenotype is associated with long-lasting neuropeptidergic and neuroplastic adaptations in the amygdala: effects of the cannabinoid receptor 1 antagonist AM251.
Topics: Aging; Amygdala; Animals; Anxiety; Brain-Derived Neurotrophic Factor; Corticotropin-Releasing Hormone; Exploratory Behavior; In Situ Hybridization; Interpersonal Relations; Male; Microfilament Proteins; Motor Activity; Nerve Tissue Proteins; Neuronal Plasticity; Neuropeptide Y; Neuropeptides; Nicotine; Nicotinic Agonists; Phenotype; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Substance Withdrawal Syndrome | 2012 |
Donepezil, an acetylcholinesterase inhibitor, attenuates nicotine self-administration and reinstatement of nicotine seeking in rats.
Topics: Analysis of Variance; Animals; Behavior, Animal; Cholinesterase Inhibitors; Conditioning, Operant; Cues; Disease Models, Animal; Donepezil; Dose-Response Relationship, Drug; Indans; Male; Nicotine; Piperidines; Rats; Reinforcement Schedule; Reinforcement, Psychology; Self Administration; Sucrose; Tobacco Use Disorder | 2014 |
Working memory- and anxiety-related behavioral effects of repeated nicotine as a stressor: the role of cannabinoid receptors.
Topics: Analysis of Variance; Animals; Anxiety; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Male; Maze Learning; Memory Disorders; Memory, Short-Term; Mice; Mice, Inbred ICR; Nicotine; Piperidines; Pyrazoles; Receptors, Cannabinoid; Restraint, Physical | 2013 |
Inhibition of glycine transporter-1 reduces cue-induced nicotine-seeking, but does not promote extinction of conditioned nicotine cue responding in the rat.
Topics: Analysis of Variance; Animals; Benzamides; Conditioning, Psychological; Cues; Discrimination Learning; Dose-Response Relationship, Drug; Drug-Seeking Behavior; Extinction, Psychological; Glycine Plasma Membrane Transport Proteins; Implosive Therapy; Male; Motor Activity; Nicotine; Piperidines; Random Allocation; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Self Administration; Sucrose | 2013 |
Acetylcholinesterase inhibition reveals endogenous nicotinic modulation of glutamate inputs to CA1 stratum radiatum interneurons in hippocampal slices.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Acetylcholine; Age Factors; Animals; Animals, Newborn; CA1 Region, Hippocampal; Cholinesterase Inhibitors; Donepezil; Electric Stimulation; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Glutamic Acid; Guinea Pigs; In Vitro Techniques; Indans; Interneurons; Lethal Dose 50; Male; Mecamylamine; Nicotine; Nicotinic Antagonists; Patch-Clamp Techniques; Piperidines; Rats; Soman | 2013 |
A role for hypocretin/orexin receptor-1 in cue-induced reinstatement of nicotine-seeking behavior.
Topics: Animals; Benzoxazoles; Conditioning, Operant; Cues; Drug-Seeking Behavior; Extinction, Psychological; Hypothalamus; Isoquinolines; Male; Mice; Microinjections; Naphthyridines; Nerve Tissue Proteins; Neurons; Nicotine; Nicotinic Agonists; Nucleus Accumbens; Orexin Receptor Antagonists; Orexin Receptors; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Piperidines; Prefrontal Cortex; Protein Kinase Inhibitors; Pyridines; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Self Administration; Signal Transduction; Urea | 2013 |
Nicotelline: a proposed biomarker and environmental tracer for particulate matter derived from tobacco smoke.
Topics: Alkaloids; Biomarkers; Chromatography, High Pressure Liquid; Dust; Environmental Monitoring; Gas Chromatography-Mass Spectrometry; Gases; Half-Life; Humans; Nicotiana; Nicotine; Particulate Matter; Piperidines; Pyridines; Reference Standards; Smoking; Tandem Mass Spectrometry; Time Factors | 2013 |
Basolateral amygdala CB1 cannabinoid receptors mediate nicotine-induced place preference.
Topics: Amygdala; Analysis of Variance; Animals; Benzoxazines; Calcium Channel Blockers; Conditioning, Operant; Dose-Response Relationship, Drug; Male; Microinjections; Morpholines; Motor Activity; Naphthalenes; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1 | 2014 |
Donepezil reverses nicotine withdrawal-induced deficits in contextual fear conditioning in C57BL/6J mice.
Topics: Animals; Cholinesterase Inhibitors; Conditioning, Psychological; Donepezil; Electroshock; Fear; Freezing Reaction, Cataleptic; Indans; Locomotion; Male; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Nootropic Agents; Piperidines; Substance Withdrawal Syndrome | 2014 |
Dopamine D3 receptors in the basolateral amygdala and the lateral habenula modulate cue-induced reinstatement of nicotine seeking.
Topics: Animals; Autoradiography; Basolateral Nuclear Complex; Conditioning, Operant; Cues; Dopamine Antagonists; Drug-Seeking Behavior; Extinction, Psychological; Habenula; Indoles; Iodine Isotopes; Male; Nicotine; Nicotinic Agonists; Nitriles; Piperidines; Rats; Rats, Long-Evans; Receptors, Dopamine D3; Reinforcement, Psychology; Self Administration; Tetrahydroisoquinolines; Tetrahydronaphthalenes | 2014 |
Nicotinic and muscarinic agonists and acetylcholinesterase inhibitors stimulate a common pathway to enhance GluN2B-NMDAR responses.
Topics: Animals; CA1 Region, Hippocampal; Cholinesterase Inhibitors; Donepezil; Excitatory Postsynaptic Potentials; Indans; Long-Term Potentiation; Muscarinic Agonists; Nicotine; Nicotinic Agonists; Piperidines; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M1; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Signal Transduction; Succinimides | 2014 |
Responding for a conditioned reinforcer, and its enhancement by nicotine, is blocked by dopamine receptor antagonists and a 5-HT(2C) receptor agonist but not by a 5-HT(2A) receptor antagonist.
Topics: Animals; Benzazepines; Conditioning, Classical; Dopamine Antagonists; Ethylamines; Fluorobenzenes; Indoles; Male; Nicotine; Piperidines; Rats, Long-Evans; Reinforcement, Psychology; Salicylamides; Serotonin 5-HT2 Receptor Antagonists | 2014 |
Inhibition of monoacylglycerol lipase reduces nicotine withdrawal.
Topics: Animals; Benzodioxoles; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Monoacylglycerol Lipases; Nicotine; Piperidines; RNA, Messenger; Substance Withdrawal Syndrome | 2015 |
Antidepressant-like effects of the cannabinoid receptor ligands in the forced swimming test in mice: mechanism of action and possible interactions with cholinergic system.
Topics: Animals; Antidepressive Agents; Cannabinoids; Depressive Disorder; Disease Models, Animal; Indoles; Ligands; Male; Mice; Motor Activity; Nicotine; Oleic Acids; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Scopolamine; Swimming | 2015 |
Nicotinic α7 and α4β2 agonists enhance the formation and retrieval of recognition memory: Potential mechanisms for cognitive performance enhancement in neurological and psychiatric disorders.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Benzamides; Bridged Bicyclo Compounds; Cholinesterase Inhibitors; Donepezil; Dose-Response Relationship, Drug; Exploratory Behavior; Female; Indans; Locomotion; Mental Recall; Nicotine; Nicotinic Agonists; Piperidines; Rats; Recognition, Psychology; Retention, Psychology; Risperidone | 2016 |
Inhibition of monoacylglycerol lipase (MAGL) enhances cue-induced reinstatement of nicotine-seeking behavior in mice.
Topics: Animals; Benzodioxoles; Cues; Drug-Seeking Behavior; Glycerides; Male; Mice; Mice, Inbred C57BL; Monoacylglycerol Lipases; Nicotine; Piperidines; Reinforcement, Psychology; Self Administration | 2016 |
Repeated administration of an acetylcholinesterase inhibitor attenuates nicotine taking in rats and smoking behavior in human smokers.
Topics: Adolescent; Adult; Animals; Cholinesterase Inhibitors; Donepezil; Female; Galantamine; Humans; Indans; Male; Middle Aged; Nicotine; Piperidines; Rats; Smoking Prevention; Young Adult | 2016 |
Self-administration of the anandamide transport inhibitor AM404 by squirrel monkeys.
Topics: Animals; Arachidonic Acids; Benzamides; Cannabinoid Receptor Antagonists; Carbamates; Cocaine; Dose-Response Relationship, Drug; Dronabinol; Drug-Seeking Behavior; Endocannabinoids; Male; Nicotine; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Reinforcement, Psychology; Reward; Rimonabant; Saimiri; Self Administration | 2016 |
Attenuation of cue-induced reinstatement of nicotine seeking by URB597 through cannabinoid CB1 receptor in rats.
Topics: Amidohydrolases; Animals; Arachidonic Acids; Benzamides; Cannabinoid Receptor Antagonists; Carbamates; Cues; Drug-Seeking Behavior; Endocannabinoids; Male; Nicotine; Piperidines; Polyunsaturated Alkamides; PPAR alpha; Pyrazoles; Rats; Rats, Long-Evans; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Tobacco Use Disorder | 2016 |
Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys.
Topics: Animals; Conditioning, Operant; Cues; Dronabinol; Drug-Seeking Behavior; Male; Marijuana Abuse; Nicotine; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Recurrence; Reinforcement, Psychology; Rimonabant; Saimiri; Self Administration; Tobacco Use Disorder | 2016 |
CB
Topics: Animals; Arachidonic Acids; Brain; Cannabinoid Receptor Antagonists; Endocannabinoids; GABAergic Neurons; Glycerides; Male; Memory; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuronal Plasticity; Nicotine; Piperidines; Polyunsaturated Alkamides; Pyramidal Cells; Pyrazoles; Receptor, Cannabinoid, CB1; Receptors, GABA; Recognition, Psychology; Rimonabant; Substance Withdrawal Syndrome | 2017 |
Fatty acid amide hydrolase (FAAH) inactivation confers enhanced sensitivity to nicotine-induced dopamine release in the mouse nucleus accumbens.
Topics: Amidohydrolases; Animals; Dopamine; Endocannabinoids; Mice; Mice, Knockout; Microdialysis; Nicotine; Nicotinic Agonists; Nucleus Accumbens; Piperidines; Pyridines | 2018 |
Effects of concurrent blockade of OX2 and CB1 receptors in the ventral tegmental area on nicotine-induced place preference in rats.
Topics: Animals; Conditioning, Operant; Dose-Response Relationship, Drug; Male; Microinjections; Nicotine; Orexin Receptor Antagonists; Orexin Receptors; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Ventral Tegmental Area | 2018 |
Functional crosstalk of nucleus accumbens CB1 and OX2 receptors in response to nicotine-induced place preference.
Topics: Animals; Conditioning, Operant; Conditioning, Psychological; Male; Nicotine; Nucleus Accumbens; Orexin Receptor Antagonists; Orexin Receptors; Piperidines; Pyrazoles; Rats, Wistar; Receptor, Cannabinoid, CB1 | 2019 |
Electrophysiological study of the response of ventral tegmental area non-dopaminergic neurons to nicotine after concurrent blockade of orexin receptor-2 and cannabinoid receptors-1.
Topics: Animals; Cannabinoids; Conditioning, Operant; Isoquinolines; Male; Neurons; Nicotine; Nucleus Accumbens; Orexin Receptor Antagonists; Orexin Receptors; Piperidines; Pyrazoles; Pyridines; Rats; Rats, Wistar; Receptors, Cannabinoid; Ventral Tegmental Area | 2019 |
Inhibition of monoacylglycerol lipase reduces nicotine reward in the conditioned place preference test in male mice.
Topics: Animals; Anti-Anxiety Agents; Arachidonic Acids; Benzodioxoles; Cannabinoid Receptor Agonists; Conditioning, Classical; Endocannabinoids; Enzyme Inhibitors; Glycerides; Male; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Monoacylglycerol Lipases; Nicotine; Piperidines; Receptor, Cannabinoid, CB1; Reward; Tobacco Use Disorder | 2020 |
Direct administration of ifenprodil and citalopram into the nucleus accumbens inhibits cue-induced nicotine seeking and associated glutamatergic plasticity.
Topics: Animals; Citalopram; Cues; Dendritic Spines; Drug-Seeking Behavior; Excitatory Amino Acid Antagonists; Extinction, Psychological; Glutamic Acid; Male; Neuronal Plasticity; Neurons; Nicotine; Nucleus Accumbens; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Selective Serotonin Reuptake Inhibitors; Self Administration | 2020 |